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ABSTRACT 
 
Breast milk is the optimal form of nutrition for the human infant. In the U.S., 77% of 
women initiate breastfeeding immediately after birth, but by 6 months post-partum, only 43% are 
still breastfeeding with only 13% being exclusively breastfed (CDC, 2009). The remaining 30% 
of mothers are using formula supplemented with breast milk or “combined feeding” (CF) (CDC, 
2009). Many infants who are receiving formula as their primary of source of nutrition are 
deprived of beneficial compounds naturally existing in human milk. One of the groups of 
bioactive components is the human milk oligosaccharides (HMO). This complex group of 
structures has many beneficial effects for the infant including promoting the growth of 
Bifidobacteria, acting as anti-adhesive and anti-microbial factors against pathogens, modulating 
immune development, and perhaps even providing nutrients for brain development (Bode, 2012). 
Prebiotics are routinely added to infant formula to mimic the actions of HMOs.  
In addition to increasing rates of formula feeding, the proportion of infants being born by 
cesarean section is also on the rise with rates being approximately 30% in the U.S. (Hamilton 
BE, 2009; Betrán AP, 2007; Mayor S, 2005).  Route of delivery can influence colonization of 
intestinal microbiota. Vaginally-delivered (VD) infants acquire microbes from their mother’s 
vaginal canal and perineum, while cesarean-derived infants obtain more microbes from the 
environment, including the mother’s skin (Biasucci et al, 2008, Dominguez-Bello et al, 2010).  
The microbes that colonize the newborn intestine influence other functions of the gut, including 
mucosal immune development (Mshviladadze and Neu, 2010).  
Herein, we have three aims to investigate the effects of these early life events on neonatal 
intestinal, microbial, and immune development.  Our first aim was to investigate the effect of 
route of delivery on microbial development and intestinal structure and function. Neonatal 
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piglets were delivered either vaginally (VD) or by cesarean (CD) sow-reared for 21 days and 
then moved to cages and fed a weaning diet until d28. Samples were collected at d3, d14, d21 
and d28 to examine effects of time. Mode of delivery did not affect digestive enzyme activity. 
Lactase and sucrase enzyme activities were measured. Lactase activity was variable over time 
(P<0.05), and sucrase activity increased over time (p<0.05). Both of these results were not 
unusual and reflect normal development in the piglet. Intestinal permeability was measured using 
the Ussing chamber. Route of delivery affect some of these parameters. CD piglets had greater 
glucose and glutamine transport at d14 compared to VD piglets. VD piglets also had increased 
jejunal basal Isc compared to CD piglets at all time points. In both the ileum and duodenum, 28-
d-old piglets showed significant electrophysiological changes when compared to other time 
points, which s may be related to weaning. Resistance was increased at d28 in the duodenum 
compared to all other days, signaling that tight junction permeability was decreased. Intestinal 
histomorphology, villus height and crypt depth were evaluated and both day and mode of 
delivery had an effect, with VD piglets having longer villi than CD piglets and villi being longer 
at d14 than any other time point. Although, there were no significant differences in weight gain 
over time between the two groups, a slight separation in growth started to occur at d14 with the 
CD piglets slowing their rate of weight gain compared to VD piglets. These two results, in 
addition to the increased glucose and glutamine transport at d14, may be connected.  
Bacterial diversity was evaluated using Terminal Restriction Fragment Length 
Polymorphism (T-RFLP). There was no effect of route on this parameter. However, day did have 
an effect with the colonic communities separating out by day. Bacterial densities in the ileum and 
AC were quantified using qPCR and both universal and group specific primers. In the ileum, 
densities of total bacteria, Clostridium cluster XIVa and Lactobacillus were stable between d3 
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and 21, then decreased at d28. The numbers of ileal Bifidobacterium and Bacteroides-Prevotella 
did not change over time. In the AC, populations of total bacteria and Clostridium cluster XIVa 
increased from d3 till 14, were stable until d21, then decreased at d28. The numbers of 
Bifidobacterium and Lactobacillus were stable prior to weaning, and then increased and 
decreased, respectively, at d28. The densities of Bacteroides-Prevotella increased from d3 to d14 
and were stable until d28.   
The products of bacteria fermentation, short chain fatty acids (SCFA), were affected by 
day, but not by route of delivery. Ileal butyrate concentrations decreased over time, reaching its 
lowest point at d28. Ileal acetate and propionate concentrations varied over time. In the 
ascending colon (AC), concentrations of all three short chain fatty acids (SCFA) remained stable 
through d21 and then increased at d28. Concentrations of branch chain fatty acids (BCFA) were 
only different in the AC, with isobutyrate and isovalerate being greatest at d14 and lowest at d28. 
Valerate concentrations in the AC were lower at d3 compared to all other days.  
In summary, changes in both intestinal parameters as well as microbiota were observed 
over time, many related to changes in diet at weaning. Route of delivery did not have the marked 
affects as previously hypothesized. This could be related to all the piglets being sow reared 
which may have lessened the impact of route of delivery on microbial colonization and in turn 
the other parameters of intestinal structure, function and permeability.  
The second aim of this dissertation focused on the effect of route of delivery and diet on 
intestinal function and immunity. Piglets were born either vaginally or through cesarean section 
and were fed one of three diets: formula, formula+prebiotic, or sow milk. The prebiotics chosen 
were polydextrose and scFOS (2g/L of each). The study duration was 14 days with a collection 
time point at d7 and d14. Dissacharidase and peptidase enzymes were examined in jejunal and 
v 
 
ileal tissues. In the jejunum, neither day nor diet had an effect on lactase activity, but day had an 
effect on sucrase activity with d14 piglets having higher sucrase activity than d7. In the ileum, 
both day (p<0.0001) and diet (p<0.0001) had an effect on lactase activity with formula fed (FF)  
piglets having highest lactase activity followed by formula+prebiotic (FP) piglets, and then  sow 
reared (SR). Lactase activity was also higher at d14 than d7. Ileal sucrase activity was also 
impacted by both day (p<0.0001) and diet (p<0.0001) with FF piglets having higher sucrase 
activity than both FP and SR piglets and activity was higher at d14 compared to d7.  
Aminopeptidase N (APN) was measured in both jejunum and ileum, and Dipeptidylpeptidase IV 
(DPPIV) was measured in jejunum and ileum, as well as serum. In the jejunum, both day 
(p=0.0023) and diet (p=0.0003) were significant, with d7 piglets having higher APN activity 
than d14. Both FF and FP piglets had higher APN activity compared to SR. In ileum, APN also 
had both day (p=0.047) and diet (p<0.0001) effects with FF piglets having significantly higher 
activity than FP and SR. Jejunal DPPIV showed effects of diet (p<0.0001) with FF piglets 
having higher activity than FP and SR. In ileum, both diet (p<0.0001) and day (p=0.0182) had 
effects with FF piglets having higher activity than FP and SR. There were no significant effects 
in blood.  
Ileal sections were stained for CD3+ T-lymphocyte populations. There was an effect of 
diet (p=0.0085) and day (p<0.0001) on population of CD3+ cells in the ileum. All groups had 
significantly more CD3+ cells at d14 compared to d7 and SR had significantly more cells 
compared to FF with FP being intermediate. Ileal cytokine expression was measured to evaluate 
Th1, Th2 and Treg cytokine expression. There were no differences between diet or day for this 
parameter.  
vi 
 
In summary, route of deliver did not affect intestinal structure or function, cytokine 
secretion or CD3+ cell populations in the intestine. The prebiotics, however, did show some 
effects with peptidase activity in both the jejunum and ileum as well as with CD3+ cell staining 
in the ileum.  Formula+prebiotic piglets had more similar overall intestinal peptidase activity to 
SR piglets compared to FF. The addition of the prebiotic may have helped to modulate this 
result. However, FP piglets had significantly lower CD3+ cell expression in the ileum compared 
to SR.  While the prebiotic creates similar effects to breast milk in some arenas, it still is not a 
complete replacement.  
The final aim of this dissertation focused on the effects of combined feeding and 
prebiotics on immune response and the colonic transcriptome. We developed a novel piglet 
model to investigate these effects. Newborn piglets were randomized into 5 groups: sow-reared 
(SR), formula fed (FF), formula+prebiotic (FP), combined fed (CF), and combined fed 
+prebiotic (CP) (n=6 per group). SR remained with the sow 24h/day and FF/FP were fed a sow 
milk replacer with or without prebiotics (GOS and Inulin; 2g/L each). CF/CP piglets were sow-
reared for 5d and were then rotated between the sow and respective formula feeding group every 
12h. On d21, piglets were intraperitoneally injected with 10ug/kg body weight of LPS. Four 
hours after infection, blood, mesenteric lymph node (MLN), spleen (SPL), and AC were 
collected and analysis performed. 
  Immunity was tested by investigating both immune cell profiles and macrophage 
activation. T-cells, B-cells, dendritic cells, and macrophages were isolated, stained, and 
measured using a flow cytometer. In blood, SR showed significantly (p<0.0001) lower 
percentage of CD4+CD8- T-helper cells, while in the MLN they were intermediate between CP 
(p=0.0264) and all other diet groups. However, SR had a significantly (p<0.0001) higher 
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percentage of B-cells compared to all other diet groups in blood. There were no significant 
differences between diet groups with dendritic cell or macrophage populations.  Both acute phase 
response pro-inflammatory cytokines, IL-6 and TNF-α, were measured using ELISA. FF piglets 
had a much higher IL-6 response than both CF and SR diet groups. There was no significant 
difference in immune reaction to TNF-α. In addition, macrophage activation pathways, classical 
versus alternative, were also tested in both MLN and SPL tissue. Both nitric oxide synthase 
(classical) and arginase (alternative) enzyme activities were evaluated. There were no significant 
differences between diet groups when measuring nitric oxide synthase activity, but CP group did 
have significantly (p<0.0001) higher expression of arginase in MLN compared to all other diet 
groups. Combined feeding with prebiotic did have some effect in response to immune stimulus 
and seemed to encourage an anti-inflammatory immune profile as evidenced by the significantly 
higher arginase production which is caused by secretion of anti-inflammatory cytokines: IL-4, 
IL-10, IL-13 (Dewals et al, 2010).  
Gene expression of FF, CF, and SR piglets was assessed using a porcine gene microarray 
(Agilent). Among the 25,273 probes on the microarray, 449 were differentially expressed (FDR 
p<0.2). Bioinformatic analyses using MetaCore, revealed that the most significant GeneGo 
pathway maps were related to apoptosis, carbohydrate metabolism, lipid metabolism and 
neuronal pathway synthesis. Based on the pathways generated and the corresponding heatmap, 
CF and SR may have more similar gene expression patterns with genes related to lipid and 
carbohydrate metabolism, and apoptosis. FF and CF may have more similar gene expression 
patterns with genes related to glucose transport.  More research is needed in this area to see how 
these differences affect future health outcomes.  
 
  
viii 
 
ACKNOWLEDGEMENTS 
 
 First, I would like to acknowledge my adviser, Dr. Sharon Donovan. She has been a great 
source of support both professionally and personally. I thank her for always keeping me on track, 
giving me good feedback, and giving me the opportunity to grow as a scientist and future 
academician. Not every adviser would allow or encourage their graduate students to explore the 
extracurricular activities offered by the Division of Nutritional Sciences, Department of Food 
Science and Human Nutrition and University. It is because of her trust and kindness that I have 
discovered what I consider to be my passion: teaching and educating the public about nutrition.  
 I would also like to thank Dr. Marcia Monaco-Siegel. I would not be as confident in my 
skills as a scientist without her. It was her patience, willingness to help, and training that has 
helped shape me into who I am today. I will be forever grateful for all the times she has helped 
me go through data, troubleshoot an experiment, to answer all my questions, or help in the 
middle of the night when the piglets are going awry. She is an invaluable asset to the Donovan 
lab.  
 I would also like to thank my research ‘partner-in-crime’, Dr. Mei Wang. We have 
worked together for the past 5 years without so much as a hitch. I could not have asked for a 
better partner. She is respectful of me, even as a junior scientist, and lets me make my own 
decisions for sections of our projects, but also let me know she was always available for help if I 
needed it. I hope that I will continue to find partners and collaborators like her in the future.  
 I would like to acknowledge my family, Sophia and Robert Radlowski, Casey Radlowski, 
and Matthew Stern, all who have been a great support for me. My parents are amazing people 
and I am so fortunate to having such loving, understanding, and giving people in my life. I would 
ix 
 
also specifically like to thank my brother, Casey Radlowski. The success of my last piglet study 
was mostly due to his reliability and support. He is a great colleague in addition to be an amazing 
brother.  I couldn’t have found a better partner in life than Matthew Stern. I have survived 
graduate school in one piece due to his understanding, support, and love.  
 In addition, I would like to thank the past and present members of the Donovan lab for all 
their help and friendship: Rose Ann Mathai, Brooke Schantz, Shannon Cope Thorum, Elizabeth 
Reznikov, Kilia Yun Liu, Jill Shunk, Dr. Min Li, Dr. Sarah Comstock, and all the undergraduates 
who have come in and out of the lab. I would also specifically like to thank Shelly Hester for her 
friendship and support this last year with finishing our theses and completing our Dietetic 
Internships. Shelly helped to make what could have been a difficult, super stressful experience, 
an enjoyable one.  
 Lastly, I would like to thank my committee members for all their guidance throughout the 
years: Dr. Kelly Swanson, Dr. Rodney Johnson, and Dr. Michael Miller. You have challenged 
me and pushed me to become a better scientist, and I thank you for that.  
  
x 
 
Table of Contents 
 
List of Abbreviations ..................................................................................................................... xi 
Chapter 1: Literature Review ...........................................................................................................1 
Chapter 2: Objectives and Aims ....................................................................................................24 
Chapter 3: The effect of route of delivery on intestinal development and microbial  
colonization ........................................................................................................................27 
Chapter 4: Route of delivery and prebiotics: Effects on intestinal structure, function, and  
immune development .........................................................................................................66 
Chapter 5:Combined feeding and prebiotics: Effects on immune development and colonic 
 gene expression in the neonatal pig  .................................................................................93 
Chapter 6: Overall conclusions and future directions ..................................................................129 
References ....................................................................................................................................133 
Appendix A: Lipopolysaccharide (LPS) pilot study to determine optimal dosage and timing 
 of peak response ..............................................................................................................145 
Appendix B:  Porcine Agilent Gene Microarray: Probe sets that were differentially expressed 
within ascending colon samples of sow reared, formula fed, and combined 
  fed piglets .........................................................................................................................150 
 
 
 
 
 
 
 
xi 
 
List of Abbreviations 
 
AC  Ascending Colon 
APC  Antigen Presenting Cell 
ARG  Arginase 
CD  Cluster of Differentiation 
CF  Combined Fed 
CP  Combined +Prebiotic 
CR  Colonization Resistance 
CD  Cesarean Derived 
DO  Day Old 
DC  Descending colon 
DC  Dendritic Cell 
DP  Degree of Polymerization 
FAE  Follicular Associated Epithelium 
FDR  False Discovery Rate 
FF  Formula Fed 
FP  Formula+Prebiotic 
GALT  Gut Associated Lymphoid Tissue 
HMO  Human Milk Oligosaccharide 
IFN  Interferon 
IL  Interleukin 
LBP  LPS Binding Protein 
LPS  Lipopolysaccharide 
xii 
 
Mφ  Macrophage 
MLN  Mesenteric Lymph Node 
NFK-B Nuclear Factor- KB 
NK  Natural Killer Cell 
NO  Nitric Oxide 
NOS  Nitric Oxide Synthase 
PDX  Polydextrose 
SCFA  Short Chain Fatty Acid 
scFOS  Short Chain Fructooligosaccharide 
scGOS  Short Chain Galactooligosaccharide 
SPL  Spleen 
SR  Sow Reared 
TGF  Transforming Growth Factor 
TNF  Tumor Necrosis Factor 
TLR  Toll Like Receptor 
VD  Vaginally Derived 
 
 
1 
 
CHAPTER 1 
LITERATURE REVIEW 
 
1. Early Nutrition for the Neonate 
The American Academy of Pediatrics recommends breastfeeding for the first 12 months 
of life; exclusively for the first 4-6 months of life (AAP, 2005).  In the U.S., 77% of babies are 
breastfed (BF) immediately after birth, but this percentage drops significantly by 3 months to 
35% and even more by 6 months postpartum (14 %) (CDC, 2011). By 12 months of age, only 
23% of infants are BF and, of those, only 12% are exclusively BF (CDC, 2011) (Figure 1.1). 
During this time, mothers are either switching from breastfeeding to formula feeding exclusively 
or they are supplementing breast milk with formula (combined feeding). These combined fed 
infants account for approximately 30% of infants at 6 months of age (CDC, 2011). However, 
how this mode of feeding impacts short- and long-term health have not yet been delineated.  
 
1.1 Bioactive Milk Components 
Breast milk, in addition to containing all essential macro- and micronutrients required by the 
human infant, contains many bioactive components (Herfel et al, 2011). These components can 
aide in microbial colonization, immune development and protection from disease.  One of these 
milk components, human milk oligosaccharides (HMO), is involved in all three of the 
developments mentioned previously. Commercial infant formulas, which are used in lieu of or 
in combination with breast milk, contain little or no naturally occurring bioactive components or 
immune cells as part of their ingredients. Some of these components may have been present in 
the bovine milk starting material, but were removed or destroyed during the processing of the 
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formula, whereas others, such as fucosylated HMO, were not present in the bovine milk starting 
material. Formula-fed infants have a different pattern of microbial colonization and immune 
development from an exclusively BF infant (Penders et al, 2006). Formulas have to be enriched 
with compounds to help promote the same effects as breast milk. Prebiotics, which will be 
discussed in Section 4 of the Literature Review, are a recent addition to formula in the U.S, and 
may be a method of promoting beneficial bacteria and immune tolerance in the formula fed (FF) 
infant.  
  
 1.1.1 Oligosaccharides   
Human milk oligosaccharides are a heterogeneous group of carbohydrates that comprise 
the third most abundant constituent in human milk (Newburg, 2001; Bode, 2012).  They are 
abundant in colostrum, the first milk released from the breast, with a concentration of 
approximately 22 g/L and are less bountiful in mature milk (12 g/L) (Erney et al, 2000). There 
are over 200 types of HMOs that have been identified and they are composed of combinations of 
the following components: glucose, galactose, fucose, N-acetylglucosamine, and N-
acetylneuraminic acid (Li et al, 2011). The HMO concentration decreases within a feeding 
period and the composition can change throughout lactation (Newburg, 2000).  Although the 
majority of HMOs are free, some oligosaccharides are found bound to glycoproteins (Kelleher & 
Lonnerdal, 2001) or glycolipids (Newburg, 2000). 
Human milk oligosaccharides are resistant to hydrolysis by gastrointestinal enzymes in 
vitro (Engfer, 2000), which would indicate that they would survive digestion in the stomach and 
small intestine in vivo. Once they reach the distal small intestine and colon, some HMOs have 
been shown to promote growth of beneficial bacteria and to help prevent growth of potentially 
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pathogenic bacteria (Boehm et al, 2004; Bode, 2012).  These oligosaccharides are also thought to 
be bifidogenic, in that they will help to promote colonization of bifidobacteria (Zivkovic et al, 
2011).  
 
 1.1.2 Immune Cells and Cytokines   
 Breastmilk also contains immune cells and cytokines that help to develop the immune 
system of the infant (Michie, 1998). The following cell types are usually present in an activated 
phenotype when found within breastmilk (Michie, 1998): Mø, neutrophils, T-cells and B-cells.  
All of these cells help protect, as well as, educate the immature immune system of the infant.  
In addition to live cells, there are a number of other immunomodulatory compounds in 
human milk, including immunoglobulins and cytokines. For example, transforming growth 
factor-beta (TGF-) and interleukin-10 (IL-10) may contribute to the development of oral 
tolerance to dietary antigens and commensal microbiota by the infant (Brandtzaeg, 2003; 
Verhasselt, 2010).  Oral tolerance is a process that often involves down-regulating immune 
responses and both TGF- and IL-10 are immunosuppressive.   
 
2. Intestinal Microbiota of the Developing Neonate 
The microbiota comprises the majority of the cells found in the human body, 
outnumbering host cells 10-to-1 (Zoetendal, 2004).  The intestinal microbiota are mostly found 
in the colon and distal small intestine, with cell numbers usually below 10
3 
cells/g in the 
stomach, 10
4
 cells/g in the upper to middle small intestine, 10
6
 cells/g in the ileum and 10
12 
cells/g in the colon (Kolida and Gibson, 2007). The microbiota serves three major functions for 
the host: metabolic, trophic and protective (Guarner et al, 2003). They produce short chain fatty 
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acids (SCFAs) that are substrates for colonocytes, and affect colonocyte cell differentiation as 
well as mucosal cell proliferation (Scheppach, 1994). Microbes also produce vitamins that are 
utilized by the host, such as menaquinone (vitamin K).  Lastly, gut microbes induce maturation 
of host immunity and help protect again pathogenic invasions (Vael and Desager, 2009).  The 
neonate’s initial inoculation of bacteria at birth is a very important step that, if missed or altered, 
could have potentially detrimental effects.  
 
2.1 Acquisition of gut microbes by the neonate 
 Fetuses are sterile in utero (Mackie et al, 1999). However, during and immediately after 
the birth process, neonates are exposed to the microbiota of their mother as well as the 
environment. When infants are delivered vaginally, they come in contact with the microbes 
found in the vaginal canal as well intestinal microbes found near the rectum. Swabs taken from 
the mouths of vaginally-derived infants immediately after birth showed Escherichia coli (E. coli) 
serotypes that matched those from the mother’s rectum (Bettelheim et al, 1974).  This initial 
engagement with microbes will initiate the colonization of the neonate’s gastrointestinal tract.  
Neonates that undergo Cesarean section are not exposed to the vaginal and intestinal 
microbiota from the mother. Instead, they are exposed to environmental bacteria that play an 
important role in their initial colonization (Biasucci et al, 2008).  Western infants born by 
Cesarean section were reported to have a pronounced delay in colonization (Eggesbo et al, 
2003).  
After birth and exposure to microbes related to delivery and environmental contaminates, 
oral and skin microbes from the mother provide a major source of bacterial inoculum for the 
newborn infant (Morelli, 2008). Suckling during feeding, as well kissing and caressing the baby, 
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are all methods of transferring mothers microbial colonies to baby. These bacteria, namely 
Enterobacteria and other Gram-positive cocci create an oxygen-reduced environment that is 
favorable for strict anaerobic bacteria, allowing for the succession from facultative anaerobic 
bacteria to strict anaerobes (Morelli, 2008).  
 
2.2 Metabolic effects of microbiota 
The SCFA are end-products of fermentation of non-digestible dietary carbohydrates by 
the bacteria that reside in the distal small intestine and colon. The SCFA can be utilized for 
energy by the host as well as the microbes. The composition and quantity of SCFA differ 
throughout the colon (Macfarlane and Macfarlane, 2003). For example, SCFA concentrations are 
higher in the proximal large intestine compared to the distal end (Macfarlane and Macfarlane, 
2003). The most predominant SCFAs are acetate, propionate and butyrate. These compounds are 
readily metabolized by the intestinal epithelium. In addition, acetate can be absorbed by the host 
and  is utilized by the liver for fatty acid synthesis (Swanson and Fahey, 2007). Propionate is 
also absorbed and transported to the liver and is eventually used as a gluconeogenic substrate 
(Swanson and Fahey, 2007). Butyrate functions primarily as an energy source for colonocytes 
and has been found to have anti-tumor (Kolida and Gibson, 2007) and anti-cancer properties 
(Swanson and Fahey, 2007). The SCFA can enhance digestion and absorption in the small 
intestine, stimulate water and sodium absorption in the colon, and affect immune function of the 
gastrointestinal tract (Donovan et al, 2008).  The production of SCFA often leads to lower pH in 
the intestine and colon that helps to keep some pathogenic bacteria from being able to reproduce 
and colonize (Mackie et al, 1999).  
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2.3 Trophic effects of microbiota 
The intestinal bacteria also promote morphological development. Intestinal epithelial 
cells (IECs) that line the gut and form a physical barrier between the lumen and the cells of the 
immune system have been shown to have decreased rates of cell turnover as well as a different 
pattern of microvilli formation in germ-free mice compared to mice colonized with a 
conventional microbiota (Abrams et al, 1963). A similar result has been shown in pigs, in which 
there was decreased cell turnover and lack of toll like receptor expression in piglets that were 
germ free compared to those that were conventional (Willing and Van Kessel, 2007).  
 
2.4 Immune-stimulating and other protective effects of microbiota 
 The commensal bacteria act as an important antigenic stimulus for the maturation of gut 
associated lymphoid tissue (GALT) (Cebra et al, 1998), which are lymphoid structures that are 
associated with the intestinal mucosa, specifically the tonsils, Peyer’s patches, lymphoid 
follicles, appendix and mesenteric lymph nodes (MLN). These tissues contain many 
conventional and unconventional lymphocytes, dendritic cells (DC), and macrophage (Mø) 
subsets (Round and Mazmanian, 2009). GALT is important because it provides the first line of 
defense against pathogens. Gnotobiotic, or germ-free, animals show extensive defects in 
development of the GALT.  They have fewer and smaller Peyer’s patches MLN (Macpherson 
and Harris, 2004). They also show impaired development of isolated lymphoid follicles (ILFs), 
which are located in the wall of the small intestine and contain B-cells, DC, stromal cells, and 
some T-cells. The ILFs are thought to maintain equilibrium between the immune system and the 
microbiota (Round and Mazmanian, 2009). ILFs usually form following the introduction of gut 
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bacteria to the intestine, suggesting that there is a dynamic relationship between the immune 
system and the microbes (Bouskra et al, 2008).   
The microbiota exerts an active role in host defense by using colonization resistance (CR) 
to protect against pathogens (Kolida and Gibson, 2007). The term CR was introduced by van der 
Waaij and colleagues in 1971 to describe the inability of potentially pathogenic microorganisms 
to colonize the GI tract (Vollaard and Clasener, 1994). Colonization resistance can be brought 
about when ‘beneficial’ bacteria, such as bifidobacteria or lactobaccili, colonize the 
gastrointestinal tract and change the intestinal environment making it uninhabitable for most 
pathogens.  
 
2.5 Differences in colonization between BF and FF neonates 
The gastrointestinal microbiota differs between exclusively BF and FF infants (Penders et 
al, 2006).  It is commonly accepted that BF infants have a microbiota largely dominated by 
bifidobacteria (Conway et al, 1997; Hascoet et al, 2011).  Breastfed neonates show higher rates 
of colonization by bacteria considered to be beneficial to health (Lactobacillus and 
bifidobacteria) (Zivkovic et al, 2010), while FF neonates tend to be colonized by bacteria that are 
thought to be potentially pathogenic (Clostridia, Bacteroidetes) (Westerbeek et al, 2004, Vael et 
al, 2009.  These bacteria communicate with the GALT and can affect immune response and 
prevalence of allergic diseases (Hascoet et al, 2011). Differences in bifidobacteria composition in 
breast versus formula fed infants has been associated with an increased pre-disposition of 
formula-fed infants to have allergies (Hascoet et al, 2011).  Children with allergies were found to 
have higher populations of clostridia and lower populations of bifidobacteria (Kalliomaki et al, 
2001).  
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2.6 Lipopolysaccharide 
 Lipopolysaccharide (LPS) is found on the outer leaflet of the outer membrane of Gram-
negative bacteria, such as Proteobacteria (E. Coli, Salmonella, and Shigella) and 
Enterobacteriaceae (Pseudomonas and Helicobacter). The core and O-polysaccharide are made 
up of hydrophilic carbohydrate polymers that are covalently attached to a hydrophobic lipid A 
portion (endotoxin)  that is embedded in the bacterial membrane (Raetz et al, 2002).  The lipid A 
portion from enteric bacteria is comprised of two phosphorylated glucosamine residues adorned 
with six acyl chains. The recognition of LPS by the immune system is highly specific, as LPS 
molecules with altered sugars, phosphates, or lipid chains lose stimulatory activity (Rietschel et 
al, 1994).  Picomolar levels of lipid A are sufficient to be detected by the immune system 
through toll like receptor (TLR)-4 and elicit an immediate immune response (Raetz et al, 2002).  
 
3. Immune Function in the Neonate 
3.1 The gastrointestinal immune system 
The intestinal immune system relies on the cells of both the innate and adaptive immune 
system to neutralize potentially pathogenic infectious agents and to maintain tolerance to dietary 
antigens and commensal bacteria (Bayne et al, 2003). The innate immune system is non-specific 
and consists of anatomical, humoral and cellular barriers to infection. The adaptive immune 
system, in contrast, is composed of lymphoid cells that are specific for pathogens. The adaptive 
immune system has the capability to recognize and remember a specific pathogen and mount 
stronger attacks each time it encounters it (Kelly et al, 2007). However, both the innate and 
adaptive systems are needed for proper immune maturation and functionality (Bayne et al, 2003).  
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The intestinal immune system has evolved highly effective mechanisms to defend against 
gut pathogens while also exhibiting tolerance to dietary and self-antigens. It is a major site of 
immune education and there is significant evidence depicting the human gut microbiota as a 
single most important factor driving that education (Kelly et al, 2007). 
 
 3.1.1 Mucosal immunity 
 The mucus layer that coats the intestinal epithelium is a barrier that protects the host from 
many an attack by invading bacteria. The mucus gel prevents direct adherence of gut bacteria to 
the epithelial surface (Corthesy et al, 2007). Beneath the mucus layer lays a single layer of 
epithelial cells that provide another physical barrier to pathogenic bacteria present in the 
intestinal lumen. The GALT provides specific host defense and encompasses the largest 
collection of immune cells in the body (Mowat & Viney, 1997).  
Peyer’s patches are sites of antigen sampling and have a role in induction of immune 
responses. They are overlaid with a special follicle-associated epithelium (FAE) and have 
antigen sampling microfold (M) cells embedded within the epithelial layer (Burkey et al, 2008). 
The area underneath the Peyer’s patch is rich in DC, B- and T-cells. The Peyer’s patch decreases 
antigen translocation across the mucosal epithelium due to selective uptake by M-cells, and is 
important for recognizing antigen and engaging an immune response (Burkey et al, 2008).  
Isolated lymphoid follicles are composed of epithelium containing M-cells overlying 
organized lymphoid tissue, but mainly contain B-cells and develop only after birth, while Peyer’s 
patches are present in the fetal gut (Murphy et al, 2008).  They function as inductive sites for 
antigen specific mucosal responses (Burkey et al, 2008).  Both the Peyer’s patches and isolated 
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lymphoid follicles are connected by lymphatics to the MLN, which are the largest lymph nodes 
in the body and also play a role in initiating an immune response to intestinal antigen.  
 
3.2 Communication between the innate and adaptive immune systems in response to infection 
 Antigens can activate the immune system through many different routes. The innate 
immune system neutralizes most assaults before they spread beyond the intestine. Two classes of 
receptors, TLR and nucleotide-binding oligomerization domain (NOD) proteins bind antigens 
and activate nuclear factor-kappa-B (NFK-B), which leads to the transcription  of cytokines, 
chemokines and antimicrobial proteins called defensins. Both of these cell types will help to 
attract other inflammatory cells and lymphocytes (Mø, neutrophils, and DC), which assist in 
induction of a specific immune response to the infectious agent.   
TLR4 is a cell surface receptor and found on the surface of Mø and myeloid DC that recognizes 
LPS. It requires a small secreted protein, MD-2, as part of its cell surface receptor complex, as 
well as CD14 (Tapping, 2009).  The LPS-binding protein (LBP) will bind LPS that is released 
from Gram-negative bacteria and then transport it to CD14 (Figure 1.2). LBP/CD14/MD-2 
creates a complex with TLR4 on the outer membrane of the Mø or DC and signals through 
MyD88 to allow translocation of  NFK-B  This transcription will cause secretion of cytokines 
(IL-1β, TNFα) into the infected area which will further the immune response (Raetz et al, 2002).  
In addition, antigen can also be taken up into the GALT by either transcytosis through an 
M-cell or by being directly captured by a dendritic cell that was sampling the luminal contents. 
DC will then process and present the antigen to the naïve T-lymphocytes found in the Peyer’s 
patches and MLNs (Murphy et al, 2008). After the immune cells are activated in the MLN, they 
are sent to the lamina propria where Mø, immunoglobulins, DC and T-cells will work to 
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eliminate pathogens and T- and B-cells will produce more cytokines, immunoglobulins, and 
antibodies (Burkey et al, 2008).  
 
3.3 Differences in immune development between breastfed and formula-fed neonates 
The neonatal immune system is naïve at birth and is dependent on environmental factors for 
education on appropriate development. Diet is a major educator for this system.  Immune 
development differs between BF and FF infants (Chirico et al, 2008; Verhasselt, 2010). These 
differences can be due to many different factors, but bioactive components and immune 
modulating cells found naturally within breast milk are proposed to be the most prominent 
reasons behind the differences (Chirico et al, 2008; Verhasselt, 2010).  Breast milk contains 
HMO that promote colonization of bacterial groups thought to be more beneficial to the host 
than others (Boehm et al, 2004). In this case, diet is helping to preferentially select which types 
of microbes will help to educate the neonatal immune system.  Breast milk also contains 
cytokines such as interleukin (IL)-1β (Hawkes et al, 2002), interleukin-1 receptor antagonist (IL-
1ra) (Dinarello, 1995), IL-2 (Bryan et al, 2006), IL-4 (Bottcher et al, 2000), IL-5 (Bottcher et al, 
2000), IL-6 (Hawkes et al, 2002), IL-8 (Michie et al, 1998), IL-10 (Bottcher et al, 2000), IL-12 
(Bryan et al, 1999), IL-18 (Takahata et al, 2001), interferon-gamma (IFN-γ) (Bottcher et al, 
2000), tumor necrosis factor-alpha (TNF-α) (Hawkes et al, 2001), transformin growth factor-beta 
(TGF-β) (Bottcher et al, 2000; Hawkes et al, 2001) and others.  It is believed that these cytokines 
reach the neonatal intestine intact because of protection from digestion by protease inhibitors 
present in human milk, such as alpha-1-anti-trypsin (Chirico et al, 2008). These cytokines, 
besides offering the neonate some protection against infection while the immune system is still 
developing, will help to prime, or sensitize, the immune system so that it responds appropriately 
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to antigens in the future. IL-10, TGF-β, and IL-1ra are all anti-inflammatory cytokines that work 
to promote tolerance and control inflammation within the neonate (Hosea Blewett et al, 2008).  
Formula, being relatively devoid of bioactive components, educates the neonatal immune 
system in a different way when compared to breastmilk. Unless specifically added, formula does 
not contain prebiotic type fibers to help with colonization resistance.  Nor does it contain any 
immunomodulators like those present in breast milk. Without exposure to these immune 
modulating components, FF infants undergo an entirely different process of immune 
development.  
Research has shown that FF infants have higher levels of circulating T-helper cells than BF 
infants, which suggests that exposure to formula, recruits naïve T-cells to the blood. This 
recruitment could be a sign that the FF infant has a propensity for an adaptive immune response 
rather than a tolerogenic response to antigens (Andersson et al, 2009). Pabst et al (1997) also 
found that FF infants had higher levels of circulating CD4+ T-cells and B-cells in comparison to 
their BF counterparts..  
 
3.4 Macrophage activation 
3.4.1 Macrophage activation pathways: Classical versus alternative 
 Macrophages can be activated by multiple pathways, depending on the products of the 
specifically activated T-helper lymphocytes. Macrophages can be classically activated by IFN- 
and IL-12, which are produced by antigen presenting cells (APC) (Gordon, 2002).  If IL-4 or IL-
13 are present within the environment, then Mø will be alternatively activated.  
Classical activation is induced in response to pathogenic invasion. Macrophages require 
IFN- as well as one of the following signals to be activated: activated CD4+ T-cell, or the CD40 
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ligand that is expressed by TH1 cells. The binding of these ligands to the receptors on the Mø cell 
membrane will induce a series of biochemical reactions that will result in the production of 
oxygen radicals and nitric oxide (NO), both of which have potent antimicrobial activity (Murphy 
et al, 2008). In addition to this, activated Mø can fuse their lysosomes more efficiently to 
phagosomes, which exposes ingested microbes to a multitude of microbiocidal lysosomal 
enzymes. The activated Mø also secrete IL-12, which will direct differentiation of naïve CD4+ 
T-cells to become TH1 effector cells. Other cytokines, such as IL-8 will also be secreted as a 
method of recruiting other immune cells to the site of infection (Murphy et al, 2008).  
Alternative activation of Mø also happens in response to pathogenic invasion. However, 
the TH2, IL-4 and IL-13, rather than IFN-  are responsible for activation in response to 
pathogens. IL-10 has also been shown to alternatively activate Mø in IL-4 deficient mice 
(Dewals et al, 2010). IL-4 and/or IL-13 will activate the Mø through either the IL-4R (IL-4 
specfic), IL-13R1 (IL-13 specific) or the IL-4R-IL-13R1 heterodimeric receptor that can 
bind either cytokine (Gordon, 2003). Both IL-4 and IL-13 up-regulate expression of the mannose 
receptor and major histocompatability class (MHC) II molecules by Mø, which then stimulates 
endocytosis and antigen presentation as well as induces chemokine secretion to recruit other 
immune cells to the site of infection. Intracellular enzymes, such as arginase, are also up-
regulated in alternatively-activated Mø (Gordon, 2003).  
In contrast to alternative activation, when Mø are activated classically, mannose receptor 
expression is decreased and Nitric Oxide Synthase (NOS) activity is increased.  On the contrary, 
when alternative activation is enacted, NOS activity is decreased and mannose receptor 
expression increases. Nitric oxide, while an efficient way to eradicate microbial or parasitic 
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pests, can do damage to the host tissue, while arginase metabolism may be relevant to the 
fibrosis and repair of inflamed tissue (Gordon, 2003) (Table 1.1). 
 
4.  Prebiotics 
A prebiotic is a nondigestible food ingredient that brings about specific changes in the 
composition or activity of the gastrointestinal microbiota that confer health benefits upon the 
host well-being and health (Roberfroid, 2007).  Prebiotics have become a popular food additive 
and offer a potential means for formula to confer similar health benefits to breast milk.  
Any dietary component that reaches the colon intact is a potential prebiotic, but three 
criteria are required to be successfully qualified as a prebiotic: 1) the ingredient should resist host 
digestion and absorption; 2) be fermented by the microbes found in the colon; and, 3) selectively 
stimulate growth or activity of one or a limited number of bacteria in the gastrointestinal tract 
(Kolida and Gibson, 2007).  
In our studies, we chose the following prebiotics to study: polydextrose (PDX), short 
chain fructooligosaccharides (scFOS), inulin, and short chain galactooligosaccharides (scGOS). 
In Chapter 3, the prebiotics PDX and scFOS were supplemented to formula, whereas in Chapter 
4 a combination of inulin and scGOS was fed to the piglets. Descriptions of each prebiotic are 
shown below. We changed the prebiotic in the second study as we wanted to look at 
fermentation throughout the distal small intestine and colon. To ensure that fermentation would 
occur throughout the distal intestine, we chose prebiotics with two different chain lengths (short 
chain GOS and long chain inulin) knowing that short chain prebiotic would most likely be 
fermented in the distal small intestine and the long chain prebiotic within various parts of the 
colon. Based on SCFA abundance, our previous data from PDX and scFOS suggested that this 
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combination was primarily fermented in the ileum and AC and not enough in the lower parts of 
the colon. This most likely had to do with the lengths of both of these prebiotics being too 
similar to each other and being fermented in similar places within the GI tract.  
 
4.1 Polydextrose 
Polydextrose is a randomly polymerized glucose oligosaccharide with 12 degrees of 
polymerization (DP) on average. It is generally recognized as safe (GRAS) for the human food 
supply and is often found in foods as a fat, sugar, or starch replacer. It has been shown to exhibit 
prebiotic properties and beneficial effects on the gut (Jie et al, 2000; Peuranen et al, 2004; 
Probert et al, 2004; Makivuokko et al, 2005). Some of these beneficial gut effects relate to by-
products of microbial colonization, such as increased butyrate production which is a preferred 
energy source for the cell. In addition, other microbial related benefits include resistance to 
colonization by pathogens, production of antimicrobial compounds and enhancement of mucosal 
integrity (Fava et al, 2007). 
 
4.2 Inulin and inulin-type fructans (fructooligosaccharides) (FOS) 
The term inulin and long-chain FOS are sometimes used interchangeably. Inulin occurs 
naturally in several foods, such as leek, asparagus, chicory, garlic, Jerusalem artichoke, banana, 
oats and soybeans. There is only trace amounts of this prebiotic found in these foods, so the 
prebiotics are typically isolated and then added to more frequently consumed foods such as 
breakfast cereals, infant foods, yogurts, breads and drinks (Kolida and Gibson, 2007). These 
dietary fibers will increase fecal mass and water content of the stool which, in turn, will improve 
bowel habits (Roberfroid, 2005).  
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Inulin-type fructans are oligo-polymers of D-fructose joined by a -(2-1) bond with an -
(1-2) linked to a D-glucose at its terminal end. Molecules with DP between 3-5 are considered 
oligofructose (also known as scFOS),while molecules with DP of 10-65 are considered inulin 
(Kolida and Gibson, 2007).  Inulin, as well as inulin-type fructans, have been found to qualify as 
a prebiotic and are also considered “bifidogenic”, meaning that they are fermented by 
Bifidobacterium. These bacteria retain the enzyme -fructofuranosidase which can break down 
inulin and its derivatives (Kolida and Gibson, 2007). Not all bacteria possess this enzyme which 
gives Bifidobacterium an advantage when confronted with inulin and inulin-type fructans. Once 
ingested, a shift is seen and Bifidobacterium colonies increase (as reported by Gibson and Wang, 
1994; Gibson et al, 1995; Mitsouka et al, 1987).  
 
4.3 Galactooligosaccharides (GOS) 
GOS are defined as a mixture of substances produced from lactose. They usually have a 
DP between 2-10, with a terminal glucose end and the rest of the polymer consisting of galactose 
dissacharides. It can be synthesized from lactose using a -galactosidase enzyme such as 
glycosyltransferase or glycohydrolase (Tzortzis and Vulevic, 2009) 
GOS is also found to be bifidogenic as well as increase populations of Lactobacillus. 
Increases in both Bifidobacterium and lactobacilli have been shown in the stool of humans fed 
GOS (Gopal et al, 2003; Tanaka et al, 1983). Bifidobacteria have the enzyme -galactosidase 
occurring naturally, which enables them to ferment GOS to 3-galactosyl lactose and other 
branched oligosaccharides. These by-products can increase the growth of Bifidobacterium 
colonies (Rabiu et al, 2001).   
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5. The Piglet as a Model for Neonatal Development 
The piglet has been used as a model for human immune development in numerous studies 
(eg: Inskeep et al, 2010; Haverson et al, 2009; Butler et al, 2008). These studies have examined 
the development of the immune system, antibody production, passive immunity and 
immunotherapy. Piglets are useful as a model for studying immunity because they allow 
researchers to control for certain variables such as transmission of maternal antibodies. Sows 
have a six layer epitheliochorial placenta that prevents immunoglobulins from being passed to 
the fetus (Butler et al, 2008).   
Piglets are not altricial, meaning that they can survive independently of being reared by 
their mother. They have similar nutritional requirements, digestive systems, and respiratory 
systems to the human infant and can be reared on bovine colostrum/milk and other milk-based 
formulas that are used for human infants (Butler et al, 2008).  
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Table 1.1: Classical vs. Alternative Activation of Mø 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Classical Alternative 
Cytokine Activators IFN-γ, IL-12 IL-4, IL-13, IL-10 
Enzyme Produced Nitric Oxide Synthase Arginase 
Action Potent anti-microbial Tissue repair, stimulate APC 
End product Nitric Oxide, Oxygen radicals Urea, Proline, and Spermine 
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Figure 1.1. Breastfeeding rates over time. Percentage of exclusively breastfed neonates 
decreases over time with only 12% of infants being breastfed at 1 year of age. Data from CDC 
(2011). 
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Figure 1.2. Immune recognition of LPS (Raetz et al, 2002) 
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Figure 1.3. Structure of polydextrose (GTC Nutrition, Golden, Co) 
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Figure 1.4. Structure of fructooligosaccharide (FOS) (GTC Nutrition, Golden, CO) 
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Figure 1.5. Structure of galactooligosaccharide (GOS) (GTC Nutrition, Golden, CO) 
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CHAPTER 2 
OBJECTIVES AND AIMS 
 
The overall objective of this research was to determine how early nutrition (sow milk-, 
combination-, or formula-feeding with or without prebiotic) impacted intestinal structural and 
functional development as well as the composition of the intestinal microbiota and immune 
development of the piglet. Three specific aims were undertaken: 
Aim 1: Determine the impact of birth route on structure and function of the intestine 
as well as microbial development. 
The overall objective of this aim was to examine how birth route, cesarean versus vaginal 
delivery, affected intestinal structure, digestive enzyme activity, intestinal permeability, and 
microbial development. Intestinal structure was evaluated by measuring intestinal villus height 
and crypt depth. Digestive enzyme activity will be assessed for differences in route. Ussing 
chamber analysis was used to measure electrophysiological parameters in the small and large 
intestine. Microbial composition was determined using qPCR and DGGE.  The working 
hypothesis for this aim was that birth route would cause differences in microbial populations, 
which would in turn effect intestinal structure, permeability and enzyme activity. 
Aim 2: Evaluate the impact of route of delivery and early nutrition with or without 
prebiotics on the immune and functional components of the small intestine.  
The overall objective of this aim was to assess how route of delivery and sows milk or 
formula, with or without prebiotics, affected immune maturation and digestive enzyme activity 
in the neonatal piglet. Sections of the small intestine was stained for CD3+ T-cells as well as 
tested for cytokine gene expression using qPCR. Digestive enzymes (dissacharidases and 
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peptidases) were investigated for diet effects. The working hypothesis for this aim was that route 
of delivery would interact with prebiotics to modulate intestinal development and immune 
development so that formula+prebiotic piglets would display similar outcomes to sow reared 
piglets when compared to formula fed.  
Aim 3: Determine the impact of combined feeding, with or without prebiotics, on 
microbial development, immune response and genetic expression. 
Aim 3 of this research uses a newly established novel piglet model of combined feeding. 
Combined feeding consists of breast milk supplemented with formula feeding. We chose to 
mimic this feeding method with having this group of piglets rotate through the two feeding styles 
every 12 hours. There is a limited amount of literature found on this topic at this time, especially 
on the effects of combined feeding and health outcomes of the infant. This research looked to 
establish a base and further our understanding about this specific group. 
3a: The overall objective of Specific Aim 3a was to further our understanding of how 
early nutrition affects immune cellularity and immunologic response. Piglets were injected with 
a small dose of LPS (10µg/kg body weight) to stimulate the immune system and cause activation 
of macrophages. T-cell, B-cell, macrophage, natural killer, and dendritic cell populations will 
also be isolated and quantified by flow cytometry.  The working hypothesis was that the 
combined fed piglets would display a distinct pattern of immune cells from that of formula-fed 
piglets and that combined-fed piglets will show increased expression of alternatively activated 
macrophages compared to formula fed piglets.  
3b: The overall objective of Specific Aim 3b was to examine potential differences at the 
level of gene transcription that are related to differences in early nutrition. Microarray analysis 
was performed on pieces of ascending colon. The working hypothesis was that combined-fed 
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piglets would have their own distinct pattern of immune related gene expression when compared 
to the two exclusive feeding groups.  
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Chapter 3 
The effect of route of delivery on intestinal development and microbial colonization 
 
ABSTRACT 
 
Rates of cesarean delivery have increased over the past 16 years, with rates reaching 
~32% in the U.S and 23% in England. (Betrán, 2007; Hamilton, 2009; Mayor, 2005).  A recent 
meta-analysis showed a 20% increase in the subsequent risk of asthma (Thavagnanam, 2008) as 
well as food allergy (Bager et al 2008; Eggesbo et al, 2003) in children delivered by cesarean 
delivery.  This increase in morbidities may be due to the differences in acquisition of commensal 
microbiota.    
Diet is a major factor that drives the microbial successional patterns after the initial 
acquisition (Mackie, 1999).  In breastfed infants, a dominance of Bifidobacterium is observed 
over the entire breastfeeding period. During the corresponding period, formula–fed infants are 
often colonized by more diverse flora, with Bacteroides, Clostridia, Enterococcus and 
Enterobacteriaceae in addition to Bifidobacterium (Balmer and Wharton, 1989; Harmsen et al 
2000). Introduction of solid food at weaning diminished differences between breast-fed and 
formula-fed infants and the microbiota becomes more complex (Mackie, 1999).  However, 
whether mode of delivery interacts with nutrition to impact the short and long-term development 
of the intestinal community is still controversial.  
Therefore, the goal of this study was to determine the impact of route of delivery on 
microbial colonization and intestinal development. We hypothesized that route of delivery would 
affect microbial colonization and in turn cause differences in intestinal permeability and 
intestinal structure and function.  
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Piglets (n = 25) were born by either vaginal or cesarean delivery (VD: n=11; CD: n=14).  
The piglets from each CD and VD sows were paired and fed by 3 VD sows for 21 d. At d 21, the 
piglets were housed individually in temperature- and light-controlled rooms and weaned onto a 
standard weaning diet until day 28.  Samples were collected at d3, d14, d21, and d28.  Duodenal, 
jejunal, and ileal small intestine as well as pieces of ascending colon were taken immediately for 
Ussing chamber analysis as well as frozen in -80⁰C for future analysis. All sections of the small 
intestine were scraped to collect mucosal lining. For microbiological study, luminal contents 
from distal ileum, and ascending colon were collected into sterile tubes and snap frozen in liquid 
nitrogen. Contents from ileum, cecum, ascending colon, and descending colon were also 
collected for short chain fatty acid analysis (SCFA).  
Mode of delivery did not affect enzyme activity, but the enzyme activity was affected by 
piglet age. Lactase and sucrase enzyme activities were measured. Lactase activity was variable 
over time (P<0.05), and sucrase activity increased over time (p<0.05). Both of these results were 
not unusual and reflect normal development in the piglet. Intestinal permeability was measured 
using the Ussing chamber. Route of delivery had an effect within this parameter. At d14, CD 
piglets had increased glucose and glutamine transport in the duodenum. In addition, VD piglets 
had increased jejunal basal Isc compared to CD piglets regardless of time point. Intestinal 
histomorphology, villus height and crypt depth, were both evaluated and both day and mode of 
delivery did have an effect on this measurement with VD piglets having longer villi than CD 
piglets and villi being longer at d14 than any other time point. Although, there were no 
significant differences in weight gain over time between the two groups, a slight separation in 
growth started to occur at d14 with the CD piglets slowing their rate of weight gain compared to 
VD piglets. These two results, in addition to the Ussing chamber data, may be connected.  
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Bacterial diversity was evaluated using Thermal Restriction Fragment Length 
Polymorphism (T-RFLP). There was no effect of route on this parameter. However, day did have 
an effect with the colonic communities separating out by day. Bacterial densities in the ileum and 
AC were quantified using qPCR and both universal and group specific primers. In the ileum, 
densities of total bacteria, Clostridium cluster XIVa and Lactobacillus were stable between d3 
and 21, then decreased at d28. The numbers of ileal Bifidobacterium and Bacteroides-Prevotella 
did not change over time. In the AC, populations of total bacteria and Clostridium cluster XIVa 
increased from d3 till 14, were stable until d21, then decreased at d28. The numbers of 
Bifidobacterium and Lactobacillus were stable prior to weaning, and then increased and 
decreased, respectively, at d28. The densities of Bacteroides-Prevotella increased from d3 to d14 
and were stable until d28.   
The products of bacterial fermentation, SCFA, were affected by day, but not by route of 
delivery. Ileal butyrate concentrations decreased over time, reaching its lowest point at d28. Ileal 
acetate and propionate concentrations varied over time. In the ascending colon (AC), 
concentrations of all three SCFA remained stable through d21 and then increased at d28. 
Concentrations of branch chain fatty acids (BCFA) were only different in the AC with 
isobutyrate and isovalerate being greatest at d14 and lowest at d28. Valerate concentrations in 
the AC were lower at d3 compared to all other days. There were no differences in BCFA in 
ileum or descending colon (DC).  
In summary, changes in intestinal function and microbial colonization were observed 
over time, with the greatest changes occurring at weaning. Route of delivery did not markedly 
affect most outcomes, possibly because all piglets were sow reared which may have lessened the 
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impact of route of delivery on microbial colonization and in turn the other parameters of 
intestinal structure, function, and permeability.  
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Introduction 
 
Rates of cesarean delivery have increased over the past 16 years, with rates reaching 
~32% in the U.S and 23% in England. (Hamilton, 2009; Betrán , 2007; Mayor , 2005).  A recent 
meta-analysis showed a 20% increase in the subsequent risk of asthma (Thavagnanam, 2008) as 
well as food allergy (Bager et al 2008; Eggesbo et al., 2003) in children delivered by cesarean 
delivery.  This increase in morbidities may be due to the differences in acquisition of commensal 
microbiota.    
Establishment of microbiota in the gastrointestinal tract is a complex process that 
involves attainment and succession of microbes until a dense and stable microbiota develops. 
Recent publications using molecular-based methods of detection have shown that the intestine of 
the meconium of newborn contains low levels of bacteria (Koenig et al. 2010; Mshvildadze and 
Neu, 2010),  however the major acquisition of intestinal bacteria begins during or immediately 
after the birth when microbes from mother and surrounding environment start to colonize the 
neonate (Scholtens et al., 2012). Infants born by caesarean section have delayed bacterial 
colonization and altered infant intestinal microbiota (Eggesbo et al, 2003; Dominguez-Bello et 
al. 2010; 2011). This delay and alteration may increase the chances of morbidities in the neonate 
that may persist throughout life (Sjögren et al, 2009). The microbiota, through its involvement in 
the nutrition, energy storage, pathological process and immune function of the host, (Gibson et 
al.,, 1995, Guarner , 2006) can modulate these different health states.  
Development of the intestinal microbiota is influenced by several factors, including host 
genotype and physiology, environmental microbes, antibiotic use, delivery mode and diet 
(Savage , 1997). Diet has been regarded as a major factor that drives the microbial successional 
patterns after the initial acquisition (Mackie , 1999).  In infants fed only breast milk, dominance 
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of Bifidobacterium was observed over the entire breastfeeding period. During the corresponding 
period, formula–fed infants are often colonized by more diverse flora, in addition to 
Bifidobacterium, also Bacteroides, Clostridia, Enterococcus and Enterobacteriaceae (Balmer 
and Wharton, 1989; Harmsen et al., 2000). Introduction of solid food at weaning diminished 
differences between breast-fed and formula-fed infants and the microbiota becomes more 
complex (Mackie, 1999).  However, whether mode of delivery interacts with nutrition to impact 
the short and long-term development of the intestinal community is still controversial.  
 Therefore, the goal of this study was to determine the impact of route of delivery on 
microbial colonization and intestinal development. Piglets were used as they have been 
recognized as a good model for the study of human neonatal nutrition (Guilloteau et al., 2010). 
Compared to rodents, pigs and humans share more similar gastrointestinal structure and function 
(Guilloteau et al., 2010). We hypothesized that route of delivery would affect microbial 
colonization and in turn cause differences in intestinal permeability and intestinal structure and 
function.  
 
Materials and Methods 
 
Animals and housing 
All animal care and experimental procedures were in accordance with the National 
Research Council Guide for the Care and Use of Laboratory Animals and were approved by the 
Institutional Animal Care and Use Committee at the University of Illinois. Piglets (n = 25) were 
born from 6 littermate sows (3 -5 piglets each sow) by either vaginal or cesarean delivery (VD: 
n=11; CD: n=14).  The piglets from each CD and VD sows were paired and fed by 3 VD sows 
for 21 d. At d 21, the piglets were housed individually in temperature- and light-controlled rooms 
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and weaned onto a standard weaning diet (Table 3.1) until day 28.  The weights of piglets were 
monitored daily. 
 
Cesarean section 
Sows, on d114 of gestation, were sedated with TKX cocktail (1cc per 300lbs) through the 
ear vein.  The TKX (Telazol, Ketamine, and Xylazine) cocktail was prepared by rehydrating 
Telazol with 2.5mL of ketamine (100 mg/mL) and 2.5mL of Xylazine (100 mg/mL). In addition, 
sows were maintained on isoflurane via a nasal cone until the time of the delivery of the piglets. 
Sows level of anesthesia was reduced to decrease sedation of the fetuses before removing the 
fetuses from the uterine horns. Assessment of depth and quality of the plane of anesthesia 
included evaluation of eye movement and monitoring of deep pain response and degree of 
muscle relaxation.  If the sow showed any response to manipulation during the surgical 
procedure, the isoflurane level was increased to the point that she was no longer responsive to 
manipulation.  
The sow’s legs were secured to a cart and the abdomen was then shaved and cleaned 3 
times with Betadine solution to disinfect the area. Sows were then injected with a local anesthetic 
(2% lidocaine) on their lower right rear flank.  Surgical coverings and tools used during all 
procedures were either one time use or disinfected and autoclaved before use in surgery. A 20cm 
incision was made along the flank and the muscles were bluntly dissected to the peritoneum. The 
peritoneum was incised and one horn of the uterus was exposed. A mid-uterine incision, 
approximately 10-15cm, was made in the greater curvature of the exposed horn and piglets were 
delivered through this incision.  After all piglets in this horn were delivered, the second horn was 
exposed and the same procedure followed.  After all piglets were delivered, the sow was 
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euthanized by sodium pentobarbital (Fatal Plus; 1 cc per 10lbs body weight, IV). The incisions 
into the sow body cavity were sutured. After being delivered, all piglet umbilical cords were 
disinfected with 7% iodine solution and clamped. Piglets were dried, placed under a heat lamp 
and stimulated to reach a stable breathing pattern.  
 
Sample collection 
All intestinal and luminal content samples were collected on postnatal d 3, 14, 21 and 28.  
Two piglets (CD=1, VD=1) from each sow were used for each sampling day when possible. 
Piglets were first sedated with Telazol (3.5 mg/kg BW each Tiletamine HCl and Zolazepam HCl, 
Pfizer Animal Health, Fort Dodge, IA). After sedation, blood was collected by cardiac puncture 
into non-coated Vacutainer tubes (BD Biosciences, Franklin Lakes, NJ) for serum isolation. 
Piglets were then euthanized by an intravenous injection of sodium pentobarbital (72 mg/kg BW 
Fatal Plus, Vortech Pharmaceuticals, Dearborn, MI). The small intestine was excised from the 
pyloric sphincter and the ileocecal valve, and its length was measured. The intestine was cut at 
10 and 85% from the proximal end to give three segments corresponding to the duodenum, 
jejunum, and ileum, respectively, on the basis of distances extrapolated from Houle et al (1997). 
The segments were flushed with ice-cold phosphate buffered saline and weighed.  The large 
intestine was isolated and separated into cecum and colon at the cecocolic junction. The colon 
was further divided equally into three segments, representing the AC, transverse and DC colon.  
Sections of duodenum, jejunum, ileum and AC were taken immediately for electrophysiological 
measurements in modified Ussing chambers. Intestinal and colonic segments were frozen at -
80C for RNA isolation, and preserved in a 10% buffered formalin solution for histomorphology 
analysis.  Remaining intestinal tissue was opened longitudinally and gently scraped with a 
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microscope slide to remove and collect the mucosal lining, then frozen in -80C for subsequent 
analysis. For microbiological analyses, luminal contents from distal ileum and AC were collected 
into sterile tubes and snap frozen in liquid nitrogen.  For short chain fatty acid (SCFA) analysis, 
the contents from ileum, cecum, ascending and descending colon were placed into glass bottles 
containing 2N HCl.  
 
Electrophysiologic measurements 
The procedures for measuring nutrient transport and barrier function in modified Ussing 
chambers have been described previously (Kles and Tappenden, 2002).  Briefly, sections of the 
duodenum, jejunum, ileum, and AC were stripped of their muscularis and mounted in modified 
Ussing chambers (Physiologic Instruments, San Diego, CA). Luminal and serosal surfaces were 
exposed to oxygenated Kreb’s buffer.  Barrier function was examined using the modified Ussing 
chambers by obtaining resistance measurements. An external pulse current was repeatedly 
applied to the mounted tissue to create a potential difference, which caused a change in short-
circuit current that was measured with the software. Using Ohm’s law, resistance was calculated 
after short-circuit current had stabilized and before any nutrients were added to the mucosal 
chamber. Sodium-dependent nutrient transport was measured by the addition of either 10mM of 
glucose or glutamine to the luminal buffer. Chloride secretion was measured by the change in Isc 
induced by the addition of either 0.1mM of carbachol or serotonin to the serosal buffer.  
 
Dissacharidase activity 
Mucosal homogenates were prepared with 0.2 g intestinal mucosa into 2 ml of 
homogenization buffer (0.9% saline solution containing 223 μmol/L iodoacetic acid and 1 
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μmol/L phenylmethylsulfonylfluoride). After preparing the appropriate dilution in 
homogenization buffer (range of no dilution to 1:20), the mucosal homogenate were incubated in 
either lactose or sucrose buffer for 60 min at 37 °C. The hydrolysis reaction of glucose released 
from the disaccharide was then stopped by the addition of zinc sulfate and barium hydroxide. 
Following centrifugation and transfer of supernatant to a 96 well microplate, the amount of 
glucose released was detected using a glucose oxidase reagent (Thermo Scientific, Middletown, 
VA), which allowed for the development of color to quantitatively measured using a microplate 
spectrophotometer (Molecular Devices Sunnyvale, CA). Disaccharidase activity was expressed 
in units of the amount of glucose released per gram of protein per minute (Dudley et al., 1992). 
 
Mucosal Protein  
Mucosal homogenates were prepared with 0.2 g intestinal mucosa into 2 mL of 
homogenization buffer. Homogenates were diluted either 1:5 or 1:10 in homogenization buffer 
and transferred to a 96-well microplate. Following the addition of Bio-Rad dye reagent, protein 
concentration was measured using a spectrophotometer (Molecular Devices Sunnyvale, CA). A 
standard curve was generated using Bovine Serum Albumin (BSA) and sterile water. 
 
Intestinal histomorphology  
Formalin fixed, paraffin-embedded intestinal and colonic samples were sliced to 
approximately 5 m with a microtome, mounted on slides, and stained with hematoxylin and 
eosin. Villus height and crypt depth were measured by using a NIKON microscope (Melville, 
NY) and Image Pro Plus software (Mediacybernetics; Bethesda, MD). 
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pH and SCFA concentration 
pH of luminal contents from ileum, cecum, AC and DC was measured using a Beckman 
pH meter and electrode (Fullerton, CA). Concentrations of SCFA were determined via gas 
chromatography as described by Erwin et al. (1961).  
DNA extraction from luminal contents 
DNA from luminal contents was isolated and purified by the QIAamp DNA Stool Mini 
Kit (Qiagen, Valencia, CA) in combination with FastPrep-24 System (MP Biomedicals, Solon, 
OH). Briefly, 200 mg (wet weight) of intestinal content was weighed to 2 ml tube containing 
glass matrix E.  One ml of ASL-buffer was added to the tube and the tube was shaken with 
Fastprep 24 at 6 m/s for 30s. The sample was then incubated at 95°C for 5 min. After 
centrifugation at 20,800g for 1 minute, 0.8 ml of supernatant was collected into a 2.0-ml tube and 
400 μL buffer ASL was added. The sample was mixed and treated with 1 InhibitEX tablet to 
remove the DNA-damaging substances and PCR inhibitors. After 3 minutes of centrifugation, 
200 μl of supernatant was treated with proteinase K, buffer AL, and precipitated with ethanol 
according to the manufacturer's instructions. DNA in the sample was further purified on a 
QIAamp spin column and eluted in 200 μl of buffer AE and stored at -20 °C.  DNA 
concentration was determined with a NanoDrop 1000 spectrophotometer (NanoDrop 
Technologies, Wilmington DE). 
 
Quantitative real-time PCR (qPCR) 
Quantitative real-time PCR were performed in Applied Biosystems 7900HT Fast Real-
Time PCR System (Carlsbad, CA). All PCR experiments were done in triplicate with a reaction 
volume of 10 µl, using MicroAmp optical 384-well reaction plates sealed with MicroAmp 
38 
 
optical adhesive film (Applied Biosystems). Each reaction contained 5 µl of 2Χ SYBR Green 
PCR Master mix (Applied Biosystems), 5 µl bovine serum albumin (New England Biolabs, 
Ipswich, MA) at 1 mg/ml (final concentration 100 µg/ml), 0.5 µM of each primer and 2µl of 
template DNA. The cycling conditions were 50ºC for 2 min, 95ºC for 10 min, followed by 40 
cycles of 95ºC for 15s, primer-specific annealing temperature (Table 3.2) for 20s and 72ºC for 
45s. Following amplification, a dissociation step was included to analyze the melting profile of 
the amplified products. Standard curves (10–10716S rRNA gene copies per reaction) were 
generated using ten-fold serial dilution of purified 2.1TOPO-TA plasmids (Invitrogen, Carlsbad, 
CA) containing the 16S rRNA gene of Eubacterium Hallii (used for quantitation of Clostridium 
cluster XIVa and total bacteria), Lactobacillus rhamnosus, Bifidobacterium longum and 
Bacteroides fragilis. Data analysis was processed with SDS v2.3 software supplied by Applied 
Biosystems. Results are presented as number of 16S rRNA gene copies per gram of intestinal 
contents.  
 
T-RFLP analysis  
The 16S rDNA genes were amplified by using bacterial primers ENV1 (5’-AGA GTT 
TGA TII TGG CTC AG-3’) and ENV2 ((5’-CGG ITA CCT TGT TAC GAC TT-3’) (Wang et 
al., 2004). The forward primer ENV1 was labeled at the 5’-end with 6-carboxyfluoresce 
(Invitrogen). The PCR reaction mixture contained 0.2 µM of each primer, 20 ng of template 
DNA, 5 µl of 10 Χ PCR reaction buffer (100 mM Tris–HCl, 500 mM KCl, pH 8.3), 200 µM of 
each deoxyribonucleotide triphosphate, 5 µl bovine serum albumin (New England Biolabs) at 1 
mg/ml (final concentration 100 µg/ml), 2 mM MgCl2 and 2.5 U of Taq DNA polymerase (Roche 
Diagnostics, Mannheim, Germany) in a total volume of 50 µl. PCR was performed in a 
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DNAEngine (Bio-Rad, Hercules, CA) using the program previously described (Wang et al., 
2004). The size (approximately 1.5 kb) of PCR products was verified on a 1% agarose gel in 
TBE buffer (89mmol/L Tris, 89 mmol/L boric acid, and 2.5 mmol/L EDTA, pH8.3) after 
staining with ethidium bromide. PCR products from 3 separate reactions were pooled and further 
purified by using the MinElute PCR purification Kit (Qiagen). DNA concentration was measured 
with NanoDrop 1000 spectrophotometer. 
 
Statistical analysis 
Statistical analysis was first performed using two-way ANOVA according to the General 
Linear Model (GLM) procedure of SAS (SAS Institute, Cary, NC). Day, mode of delivery and 
day x delivery were used in the statistical model. When no significant effects were detected for 
delivery and day x delivery, these were removed from the statistical model. The data were 
pooled by day and one-way ANOVA was used to analyze the day effect. When significant 
differences were detected within the treatment, least significant difference test was used to 
identify differences between individual means. For all the comparisons, statistical significance 
was set at p ≤ 0.05 and data are expressed as mean ± S.D.  
 For Ussing Chamber analysis the MIXED procedure in SAS was performed. Shapiro-
Wilk’s and Spearman’s correlation procedures were performed on residuals to assess normality 
and homogeneity, respectively.  Log transformations were performed on the following data sets: 
colonic voltage difference, basal short circuit current, and serotonin, jejunal serotonin, ileal 
glucose and glutamine, and duodenal basal short circuit current.  Reciprocal transformations 
were performed on ileal and duodenal conductance data sets.  A square root transformation was 
performed on colonic glutamine values.  Standard error for retransformed data is presented as an 
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average of SE values calculated from both the upper and lower retransformed confidence 
intervals of group means. Comparisons were made using F-tests.  Significant data was identified 
as p≤.05 and trends identified by p≤.10.   
For T-RFLP analysis, the numbers of peak in each community were counted. Shannon 
index and Simpson index of diversity were calculated by using the following equations: 
 and , where pi is the relative abundance of the ith peak in the 
community.  The use of 1/D (Simpson index of diversity) instead of the original formulation of 
the Simpson index ensures that the value of the index will increase with increasing diversity. For 
cluster analysis, data were sorted by the R package RiboSort. Bray-Cutis dissimilarity indices 
were computed using function vegdist in R package vegan. Hierarchic clustering of T-RFLP 
profiles was performed using function hclust with unweighted pair-group method using average 
(UPGMA). Only the T-RFs that had relative abundance of 1% or greater were considered in the 
analysis. 
Results 
Body weight gain and intestinal morphometry  
Piglet growth curves are shown in Figure 3.1.  There was no effect of route of delivery 
on weight gain and mean body weight increased from 1.9 ± 0.37 kg on d 3 to 8.4 ± 2.0 kg on d 
28.  Intestinal weights and lengths are summarized in Table 3.3.  There was no effect of route of 
delivery, so data were pooled by day.  Intestinal weight (p<0.0001) and length (p<0.0001) 
increased over time. When standardized by weight (kg BW), intestinal weights were highest at 
d14 and 28 (p<0.0001) compared to the other two time-points. Intestinal length standardized by 
weight (cm/kg BW) decreased over time.  
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Digestive Enzyme Activity  
Lactase and sucrase activities were measured in the duodenum, jejunum and ileum as 
indicators of digestive function and gut maturation. Mode of delivery did not impact lactase or 
sucrase activity, but the experimental day did.  Lactase activity was highest at d21 and showed 
similar activity to day 3. Days 14 and 28 also showed similar lactase activity and were 
statistically different from d3 and d21 (Figure 3.2). Sucrase activity increased with time in all 
segments (Figure 3.3). The increase in activity was not statistically different between days 3 and 
14 or between days 21 and 28, but was significantly different between days 14 and 21. 
 
Intestinal histomorphology 
Small intestinal villus height and colonic crypt depth were measured. In the small 
intestine, both route of delivery (p=0.047) (Table 3.4), and day (p=0.03) (Figure 3.4) had 
significant effects, but there were no interactions. Vaginally-delivered piglets had greater villus 
height than their cesarean-derived counterparts. Villus height was greatest at d14 and was similar 
to d3, but statistically different from d21. The crypt depth of the AC and DC colon were 
measured. Neither delivery mode nor experimental day had effects on crypt depth (Table 3.5). 
Samples collected from d28 piglets were not able to be measured. 
 
Intestinal electrophysiology 
Route of delivery did have an effect within this parameter. Duodenal conductance was 
significantly lower (p<0.0001) and in turn, resistance significantly higher (p<0.0001) in 28 day 
old (do) piglets than all other time points (Table 3.6).  Duodenal basal short circuit current was 
significantly lower in 3 do cesarean piglets (p=0.0164) than all other time points of both CD and 
42 
 
VD piglets (Table 3.7).  Duodenal voltage difference of 3 do CD piglets was significantly lower 
than all other time points of CD and VD piglets except VD 14 do piglets (p=0.0408) (Table 3.7).  
The mean of the 14 do VD piglets was statistically similar to all groups except 3 do VD piglets 
which had much greater voltage difference.  This decrease in voltage difference from 3 to 14 do 
VD piglets was no longer present at 21 and 28 days of age.  Fourteen do CD  piglets had 
significantly higher (p=0.0364) duodenal glucose transport than all other time points of  VD and 
CD piglets  except 3 do cesarean and 21 do vaginally birthed piglets (Table 3.7).  Fourteen and 
28 do VD and 28 do CD piglets had significantly lower duodenal glucose transport than 3 do VD  
and 21 do CD piglets.  Duodenal glucose transport was significantly greater (p=0.0065) in 14 do 
piglets than 3, 21, and 28, and greater in 3 and 21 than 28 do piglets (Table 3.7).  
There was no difference in jejunal resistance values between the VD and CD groups 
meaning that barrier function remained intact in VD piglets even in the presence of higher ion 
flux.   Cesarean section did not affect jejunal passive transport; however, may have decreased 
potential basal ionic activity of the jejunal tissue.  Jejunal tissues of 14 do piglets transported 
glutamine at significantly greater levels than tissues at all other time points (p=0.0103) (Table 
3.6).   
Day 3 piglets, regardless of delivery method, had reduced ileal conductance in 
comparison to 14 and 28 do piglets (Table 3.6).  CD day 3 piglets had significantly lower ileal 
voltage difference (p=0.0167) than 14 and 28d cesarean piglets and 3 day and 28 do VD piglets 
but was statistically similar to 14 do VD and 21 do CD and VD piglets (Table 3.6).  In addition, 
ileal basal short circuit current was also significantly lower (p=0.0252) in the CD 3d piglets than 
14 and 28d CD piglets and 28 do VD piglets (Table 3.7).  As in the duodenum, the mean of the 
cesarean day 3 group was a negative value for both voltage difference and basal short circuit 
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current indicating that the 3 day cesarean ileal tissue flux is more dominantly a serosal to 
mucosal ionic flux or that the tissue is more secretory than absorptive in nature.  The 
significantly higher voltage difference between the 3d VD piglets and 3d CD piglets indicates a 
much higher basal ionic activity of this tissue.  Ileal voltage difference and basal short circuit 
current were significantly lower (p<0.05)  in VD piglets at day 14 in comparison to 3d piglets of 
both delivery routes, but this decrease was no longer seen by days 21 and 28.  Glucose transport 
in the ileum of 14d vaginally birthed piglets was significantly lower (p=0.0197) than all other 
time points of both cesarean and vaginal birth routes.  Ileal glutamine transport was higher in 14 
and 28d piglets than 3 and 21d piglets (Table 3.6).  Ileal serotonin-induced chloride transport 
was significantly lower (p=0.0101) in 28d piglets compared to all other time points (Table 3.6).   
Colon tissue of 28d piglets had significantly decreased colonic voltage difference 
(p=0.0014) and basal short circuit current (p=0.0033) than colonic tissue of piglets at 3, 14, and 
21 days of age (Table 3.6).  This decrease in 28d piglets is indicative of lower basal levels of 
colonic tissue activity.  However, there was no difference in colonic resistance values among 
these time points showing that the higher levels of activity at days 3, 14, and 21 did not translate 
to lowered barrier function at these time points.  Fourteen day old piglets showed an increase in 
colonic glutamine transport and a significant increase (p=0.0415) in colonic serotonin induced 
chloride secretion (Table 3.6).   
 
Luminal contents pH and SCFA concentrations 
pH and SCFA concentrations were measured in ileal, AC and DC contents. There were 
no effects of route, so significant differences in pH and SCFA concentrations were pooled and 
detected by experimental day (Table 3.8), but not by delivery mode. No differences in pH were 
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observed in ileum or DC during the entire experimental period. The pH of AC contents was 
similar from d3 to d21, but decreased significantly at d 28.  
In ileum, concentrations of acetate and propionate were similar between d3 and 14, 
increased at d21, and then decreased at d28. Ileal butyrate concentrations were greatest at d3 and 
lowest at d28.  In AC, acetate, propionate and butyrate concentrations were stable from d3 to 
d21, and then increased at d28. No differences in SCFA concentrations were observed in 
descending colon over time except for higher concentration of acetate at d28.  For BCFA, the 
concentrations of isobutyrate and isovalerate in ascending colon were greatest at d14, and lowest 
at d28. Valerate concentrations in ascending colon were lower at d3 compare to other days. No 
differences in BCFA were found in ileum and DC.  
 
 
T-RFLP Analysis of Bacterial Communities 
 
The bacterial diversity from samples of different experimental day and route of delivery 
were evaluated by counting the numbers of T-RFLP peaks and calculated the Shannon index and 
Simpson index of diversity (Table 3.9). For ileal samples digested with the AluI restriction 
enzyme, the Shannon and Simpson diversity indices were similar between d3 and 21, and then 
decreased at d28 . The same trend was observed when MspI was used.  The numbers of peaks in 
ileal samples decreased from d3 to 14, was stable until d21, then further decreased after weaning 
for MspI digestion, however, no significant difference in the number of peaks was found when 
AluI was used for cutting.  For AC samples, the Shannon and Simpson diversity indices were 
decreased from d3 to 14, stable until d21 and then decreased at d28 when using both AluI and 
MspI for digestion. The same was true for numbers of peak after cutting with MspI. A similar 
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trend was seen for the numbers of peak after AluI digestion, but no statistically significant 
differences were obtained.  
The changes in ileal and colonic communities over time were analyzed using hierarchic 
clustering of T-RFLP pattern from each piglet.  No clear clusters were found by day or mode of 
delivery from ileal samples. However, the colonic communities (T-RFLP patterns) were 
separated into three distinct clusters by day (d3, d14 and 21, and d28; Figure 3.5). No clear 
clusters were identified between VD and CD piglets for samples from AC. 
 
Quantitative Real-time PCR (qPCR) 
Bacterial densities in ileum and AC were quantified by qPCR with universal and group-
specific primers (Table 3.1). In ileum (Figure 3.6), the densities of total bacteria, Clostridium 
cluster XIVa and Lactobacillus were stable between d3 and 21, then decreased at d28. The 
numbers of ileal Bifidobacterium and Bacteroides-Prevotella did not change over time. In the 
AC, (Figure 3.7) populations of total bacteria and Clostridium cluster XIVa increased from d3 
till 14, were stable until d21, then decreased at d28. The numbers of Bifidobacterium and 
Lactobacillus were stable prior to weaning, increase and decreased, respectively, at d28. The 
densities of Bacteroides-Prevotella increased from d3 to d14 and were stable until d28.  No 
significant differences on bacterial populations were detected by mode of delivery.  
 
Discussion 
Route of delivery may play an important role in development of intestinal microbiota as 
well as affect gut development. Gut structure and function were also examined to investigate if 
route of delivery affected dissacharidase activity or villus height and crypt depth. Lactase activity 
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showed variability over time which is not uncommon, as similar results have been seen in a 
study done by Manners and Stevens (1972).  Sucrase activity increased over time, which reflects 
the normal developmental ontogeny of the intestine (Adeola and King, 2006, Ekstrom et al, 
1975). These two measures were not affected by differences in route of delivery.  
Small intestine histomorphological measurements showed that jejunum had the highest 
villus height followed by the duodenum and then the ileum. This follows descriptions of normal 
growth in piglets according to Moughan et al (1992). Vaginally-derived piglets showed greater 
villus height when compared to cesarean derived piglets. This may be related to the slight slow 
in growth in the CD group. Although there were no significant differences in body weight gain 
over time, there was a slight separation between the two groups starting at d14. Perhaps this 
stunting of villi in the CD group compared to the VD group, was enough to cause a sub-optimal 
weight gain in this group. We also see that there is an increase in glucose and glutamine transport 
in CD piglets compared to VD at d14. An increase in glucose and glutamine transport can signal 
that tight junction permeability in the intestine may be in jeopardy. Although resistance, another 
measure of tight junction permeability, was not significantly different between CD and VD 
piglets, all piglets showed a decrease in duodenal resistance at d14 compared to all other time 
points. A decrease in resistance in combination with an increase in glucose and glutamine 
transport can signal that CD piglets may have had a slightly leakier gut compared to the VD 
group. Changes in intestinal permeability have been shown to relate to a decrease in villus height 
(Peuhkuri et al, 2010) which could then potentially lead to a decrease in body weight gain.  
However, in both the ileum and duodenum, 28-do piglets showed significant 
electrophysiological changes when compared to other time points. This may be related to 
weaning. Resistance was increased at d28 in the duodenum compared to all other days, signaling 
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that tight junction permeability was decreased. This was associated with a decrease in glucose 
and glutamine transport in the duodenum, and a decrease in carbachol-induced chloride secretion 
in the ileum, at d28 compared to all other time points. Studies have shown that buyrate can 
enhance barrier function and decrease intestinal permeability (Peng et al, 2009). Our results 
showed an increase in butyrate concentration at day 28, which may be responsible for the piglets 
retaining barrier function after weaning.  
Since cultured-based methods detect only a small fraction of the bacteria in the intestine 
this technique may not provide full picture of microbial diversity. Over the past decade, DNA-
based fingerprint techniques such as T-RFLP have proven to be valuable tools in characterizing 
complex bacterial communities in the environment. In our study, bacterial universal 16S rDNA 
T-RFLP was employed to compare ileal and colonic microbiota of piglets at 3, 14, 21 and 28 
postnatal days.  Results from cluster analysis revealed 3 distinct clusters representing piglets at 
d3, d14 and 21, and d28 (Figure 3.5). Our results indicate that colonic microbiota of 3 do piglets 
differs from that of 14 and 21 days old piglets. The bacterial communities are stable from 14 to 
21 postnatal days, then changed again after weaning (d28). This finding is in line with previous 
studies (Inoue 2005; Swords, 1993) and further supported by our results from real-time PCR and 
SCFA analysis as will be described below.  
Weaning is a stressful process for the piglet as it experiences an abrupt separation from 
the sow, changes in physical environments, the end of lactation-associated immunity and 
exposure to solid diet. As the weaning progresses, the piglets can become very susceptible to gut 
disorders, infections and diarrhea (Hopwood and Hampson, 2003). The weaning transition of 
piglets is associated with a compromised small intestinal mucosal integrity  (Kelly et al., 1991; 
McCracken et al., 1995; Spreeuwenberg et al., 2001). Studies on the intestinal microbiota of 
48 
 
piglets have demonstrated that weaning causes substantial changes in the intestinal bacterial 
community (Franklin, 2002, Inoue, 2005; Konstantinov, 2006; Castillo 2007).  In agreement with 
previous studies, our results show that weaning induced marked change in both the ileal and 
colonic microbiota of piglets. The cluster analysis of T-RFLP profiles clearly separated the AC 
samples collected at post weaning (d28) from those obtained at suckling period (d3, 14 and 21). 
The densities of total bacteria, Clostridium cluster XIVa and Lactobacillus significantly 
decreased at 7 days post-weaning. Similar to another study (Franklin 2002), we also found a 
paradoxical increase in colonic Bifidobacterium population after weaning.  
Corresponding to the changes in bacterial communities, differences in bacterial metabolic 
activities before and after weaning were also observed in ileum and AC. The concentrations of 
acetate, propionate and butyrate declined dramatically in ileum, but increased in AC post 
weaning. The exposure to the weaning diet that contains fermentable substrates likely drives this 
shift.  Our results showed that total bacterial density decreased in the ileum after weaning, which 
could correlate with a decreased SCFA production in that region of the intestine.  We also see an 
increase in Bifidobacterium at day 28, which may be partially responsible for the increase in 
SCFA production in the AC, as they are carbohydrate fermenters. In addition, our data 
demonstrated the bacterial communities in both the ileum and AC became less diverse after 
weaning. Again, exposure to the weaning diet is most likely responsible for this. Those bacterial 
colonies that could succeed at metabolizing and fermenting the new diet were able to stabilize 
themselves more readily within the colon and began the process of establishing the base for what 
will most likely remain the consistent pattern of microbial colonization for remainder of the 
piglet’s existence. In summary we saw changes in both intestinal parameters as well as 
microbiota over time, many related to changes in diet at weaning. Route of delivery did not have 
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the marked affects as previously hypothesized. This could be related to all the piglets being sow 
reared which may have lessened the impact of route of delivery on microbial colonization and in 
turn the other parameters of intestinal structure, function, and permeability. Possible differences 
caused by route of delivery may be easier to discern if the sow-reared piglets, which are raised in 
the same pen, were to be compared to formula-fed piglets, which are raised in separate chambers 
from each other. This may help control some of the environmental effects as well as introduce 
diet as a factor in intestinal development and microbial colonization. The combination of these 
two variables may provide some interesting results for our existing parameters as well as widen 
our scope and examine immune development as well.  
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Ingredient Pound per ton 
Corn 610.2 
Whey 500 
Soy bean meal 404.8 
Lactose 200 
Appetein 150 
Fat 60 
Lime 22.8 
Pulmotil 18 15 
Dical 12.6 
Zinc Oxide 8 
Swine Tm 7 
Vitmix ADEK 4 
DL Methionine 2.8 
Salt-White 2 
Lysine 0.8 
Table 3.1 Phase-1 weaning diet fed to piglets on day 21-28.  
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Table 3.2. Quantitative real-time PCR primers used in this study. 
Primer Target group Sequence (5’-3’) 
Annealing 
temperature (ºC) 
Reference 
Uni331F 
Uin797R 
Total bacteria 
TCCTACGGGAGGCAGCAGT 
GGACTACCAGGGTATCTATCCTGTT 
60 Nadkarni MA, 2002 
Bac303F 
Bac708R 
Bacteroides-Prevotella 
group 
GAAGGTCCCCCACATTG 
CAATCGGAGTTCTTCGTG 
56 Bartosch S, 2004 
Bif164F 
Bif662R 
Bifidobacterium 
GGGTGGTAATGCCGGATG 
CCACCGTTACACCGGGAA 
60 Kok RG 1996 
g-Ccoc-F 
g-Ccoc-R 
Clostridium cluster XIVa 
AAATGACGGTACCTGACTAA 
CTTTGAGTTTCATTCTTGCGAA 
50 Matsuki, T, 2002 
LacF 
LacR 
Lactobacillus 
AGCAGTAGGGAATCTTCCA 
CACCGCTACACATGGAG 
58 Rinttila  T, 2004 
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Table 3.3. Intestinal weights and lengths of piglets of different ages. 
 Intestinal Weight Intestinal Length 
Day g g/kg cm cm/kg 
3 49.8 ±13.4
c 
 25.9 ±2.4
b
  495 ±36.3
d
  253.7 ±23.6
a 
 
14 153.1±25.8
b
 32.4±2.4
a
 744.2±79.6
c
 159.31±19.5
b
 
21 160.2±28.2
b
 23.7±1.9
b
 896.3±49.7
b
 129.8±14.8
c
 
28 239.1 ± 47.1
a
 28.6±2.9
a
 1000.7±84.2
a
 122.9±20.1
d
 
Values are presented as means ± SD, n = 6 (d3), n = 6 (d14), n= 6 (d21) and n= 7 (d28). Means in a column without a common letter 
differ, p ≤ 0.05. 
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       Intestinal 
Segment 
Route Day 3 
 
Day 14 
 
Day 21 
DD 
CD 593.39 ± 92.22
b
 
 
619.86 ± 3.81
b
 
 
503.94 ± 5.98
b
 
VD 
630.47 ± 56.83
a
 
 
633.60 ± 51.69
a
 
 
463.04 ± 228.84
a
 
JJ 
CD 
1152.10 ± 154.61
b
 
 
912.95 ± 91.56
b
 
 
675.92 ± 133.42
b
 
VD 1125.59 ± 65.95
a
 
 
1005.52 ± 150.62
a
 
 
993.06 ± 17.31
a
 
IL 
CD 
329.68 ± 113.80
b
 
 
339.08±10.2
b
 
 
257.77 ± 51.79
b
 
VD 
421.04 ± 50.25
a
 
 
553.62 ± 227.25
a
 
 
285.68±9.4
a
 
Table 3.4. Small intestinal villus height. Route of delivery (p=0.047), had a significant effect. Vaginally delivered piglets had 
greater villus height than their cesarean derived counterparts.  
Values are presented as means ± SD, DD= Duodenum, JJ= Jejunum, IL=Ileum, CD= cesarean derived piglet, VD= vaginally 
derived piglet. Letters represent statistical differences (p ≤ 0.05) in means between routes of delivery within each day and within 
each segment of the intestine.  
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 Day 
Colonic Segment 3 14 21 
AC 308.8±43.6 292.7±29.9 267.9±25.9 
DC 358.7±85.0 422.9±73.1 375.9±15.2 
Table 3.5. Colonic crypt depth. Neither day nor route of delivery had a significant effect on colonic crypt depth.  
Values are presented as means ± SD; AC= Ascending colon, DC= descending colon  
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Intestinal 
Segment 
Day Resistance Conductance ∆ Voltage Basal Isc Glc Gln CCH 5ht 
DD 
3 56.15±10.1
b
 9.04±2.15
a
 
Interaction was statistically significant.  
See Table 3.7 for results. 
11.1±2.5
b
 10.1±7.4 8.5±0.6 
14 32.4±10.1
b
 16.1±11.34
a
 17.62±2.6
a
 82.4±44 4.2±0.4 
21 46.3±9.31
b
 11.24±3.26
a
 11.24±2.5
b
 8.8±5.8 2.5±0.7 
28 115.5±8.5
a
 4.4±0.37
b
 5.11±2.3
c
 5.4±6.8 1.4±0.8 
JJ 
3 63.4±16 8±3.3 
See Table 3.7 
25.7±25.4 5.8±7.4 5.41±3.11
b
 8.5±22.7 2.22±1.59 
14 63±15.9 8.1±3.4 28.1±23 1.1±2.7 19.1±2.9
a
 37.3±20.7 6.96±3.55 
21 62.2±15 8.4±3.3 30.2±20.6 4.6±4.9 11.4±2.9
b
 9.3±19 13.3±6.6 
28 79.3±13 6.5±1.5 21.7±14.1 3.7±4.1 7.4±2.7
b
 13.5±19.8 7.8±3.68 
IL 
3 59.4±9.5 8.4±1.15 9.3±4 
See Table 3.7 
22.6±14.6
bc
 15.5±4.8 11.9±4.6 11.8±3.25
a
 
14 54.4±10.6 14.85±4.14 1.3±0.7 22.5±15
c
 28.2±8.52 12.5±5.1 14.9±3.25
a
 
21 46.3±9.9 10.8±1.9 1±0.7 44.4±31
ab
 14.4±4.6 13.6±4.8 12.7±3.3
a
 
28 38.9±8.9 13.64±3.04 2.4±0.7 103.9±61.4
a
 28.5±8.2 -0.6±3 0.75±3.08
b
 
Colon 
3 66.9±11.4 7.8±1.9 1.86±0.49
a
 29.16±8.97
a
 0.3±0.6 3.99±4.4 4±2.7 3.64±2.3 
14 49.5±14 10.8±2.2 1.73±0.57
ab
 31.21±10.69
a
 20.7±14.6 28.43±7.9 4.4±3.5 9.63±5.95 
21 55.4±12.1 10.5±1.9 1.67±0.45
ab
 33.5±10.5
a
 2.1±1.8 8.47±4.17 2.5±2.1 2.88±1.96 
28 55.4±11.4 10.4±1.8 0.44±0.11
b
 7.66±2.35
b
 0.62±0.7 11.7±4.4 1.5±1.2 0.66±0.75 
Values are presented as means ± SD; DD= Duodenum, JJ= Jejunum, IL=Ileum. Letters represent statistical differences (p≤0.05) 
within each day and within each segment of the intestine.  
Table 3.6:  Ussing Chamber analysis of small intestinal and colon samples was affected by day only. Route of delivery did not 
have an effect. Different measures of intestinal permeability and barrier function were analyzed.  
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Intestinal 
Segment 
Day Route ∆ Voltage Basal Isc Glucose 
DD 
3 
CD -0.2±0.6
b
 -1.4±1.3
b
 11.7±5
abc
 
VD 2.2±0.5
a
 33.9±31.9
a
 9.3±4
bc
 
14 
CD 1.6±0.6
ab
 44.2±56.8
a
 24.3±5
a
 
VD 0.7±0.5
b
 7.2±8.2
a
 5.8±4
c
 
21 
CD 1.4±0.4
ab
 24.6±19.9
a
 8.4±3.5
bc
 
VD 0.8±0.6
ab
 16.5±22.7
a
 20.2±5
ab
 
28 
CD 1.1±0.4
ab
 8.1±7.5
a
 2.0±3.5
c
 
VD 1.0±0.5
ab
 11.1±11.6
a
 1.6±4
c
 
JJ 
3 
CD -0.2±0.8
 b
   
VD 1.7±0.7
 a
   
14 
CD 0.7±0.7
 b
   
VD 2.9±0.8
 a
   
21 
CD 1.8±0.6
 b
   
VD 2.23±0.8
 a
   
28 
CD 0.9±0.6
 b
   
VD 1.6±0.7
 a
   
IL 
3 CD  -14.7±19.9
b
  
 VD  31.6±19.9
ab
  
14 CD  69.5±19.9
ac
  
 VD  -0.7±19.9
b
  
21 CD  25.2±19.9
bc
  
 VD  35.3±23.8
ab
  
28 CD  76.3±18.3
a
  
 VD  51.9±19.9
ac
  
Values are presented as means ± SD; DD= Duodenum, JJ= Jejunum, IL=Ileum, CD= 
cesarean derived piglet, VD= vaginally derived piglet. Letters represent statistical 
differences (p≤0.05) within each route of delivery and within each segment of the intestine 
over time.  
Table 3.7  Ussing Chamber analysis from small intestinal samples affected by route of 
delivery. Different measures of intestinal permeability and barrier function were analyzed.  
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Table 3.8.  pH and SCFA and BCFA concentrations of ileum, cecum, ascending and descending colon contents from piglets of 
different ages. 
  SCFA BCFA  
Age (d) pH Acetate Propionate Butyrate Isobutyrate Valerate Isovalerate 
IL        
3 7.53 ± 0.19
a
 9.51 ± 2.62
a
 1.63 ± 0.97
ab
 1.25 ± 0.92
a
 0.21 ± 0.15
a
 0 ± 0
a
      0 ± 0
a
 
14 7.48 ± 0.23
a
 6.13 ± 4.90
a
 0.85 ± 0.43
ac
 0.48 ± 0.33
bc
 0.22 ± 0.11
a
 0.01 ± 0.03
a
 0.01 ± 0.03
a
 
21 7.21 ± 0.23
a
 21.73 ± 6.30
b
 2.17 ± 0.98
b
 0.81 ± 0.27
ab
 0.52 ± 0.40
a
 0.03 ± 0.07
a
 0.15 ± 0.23
a
 
28 7.35 ± 0.27
a
 7.89 ± 1.53
a
 0.10 ± 0.04
c
 0.07 ± 0.06
c
 0.03 ± 0.07
a
 0 ± 0
a
       0 ± 0
a
 
AC 
3 6.89 ± 0.29
a
 12.21 ± 2.02
a
 2.73 ± 0.87
a
 1.64 ± 0.47
a
 0.54 ± 0.26
ab
 0.09 ± 0.12
a
 0.25 ± 0.38
ac
 
14 6.92 ± 0.35
a
 10.72 ± 2.79
a
 3.57 ± 1.40
a
 1.38 ± 0.63
a
 0.72 ± 0.30
a
 0.68 ± 0.35
b
 0.87 ± 0.40
b
 
21 6.61 ± 0.46
a
 7.11 ± 1.66
a
 1.54 ± 0.86
a
 0.76 ± 0.38
a
 0.30 ± 0.17
bc
 0.41 ± 0.20
ab
 0.56 ± 0.38
ab
 
28 5.64 ± 0.34
b
 34.02 ± 8.61
b
 11.91 ± 7.93
b
 5.90 ± 2.84
b
 0.06 ± 0.08
c
 0.63 ± 0.42
b
 0.03 ± 0.07
c
 
DC 
3 6.86 ± 0.13
a
 10.75 ± 1.15
a
 2.68 ± 0.66
a
 3.27 ± 0.64
a
 1.44 ± 0.59
a
 0.69 ± 0.32
a
 1.19 ± 0.42
a
 
14 6.92 ± 0.54
a
 10.63 ± 1.63
a
 3.03 ± 1.06
a
 1.67 ± 0.29
a
 0.91 ± 0.17
a
 0.69 ± 0.21
a
 1.31 ± 0.22
a
 
21 6.33 ± 0.59
a
 15.45 ± 1.97
a
 3.78 ± 4.91
a
 2.98 ± 3.01
a
 1.08 ± 1.12
a
 1.25 ± 1.15
a
 1.99 ± 1.28
a
 
28 6.53 ± 0.56
a
 27.14 ± 8.40
b
 6.79 ± 3.18
a
 5.65 ± 3.53
a
 0.93 ± 0.92
a
 1.52 ± 1.38
a
 1.45 ± 1.60
a
 
Values are presented as means ± SD, n = 6 (d3), n = 6 (d14), n= 6 (d21) and n= 7 (d28). Within same segment, means in a column 
without a common letter differ, p ≤ 0.05. AC=Ascending Colon, DC=Descending Colon, IL=Ileum 
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Table 3.9. Diversity measures for T-RFLP of Alu-I and MspI-digested 16S rDNA amplified from contents of ileum and ascending 
colon of piglets at different ages.  
 Restriction Enzymes Number of peaks Shannon
1
 Simpson
2
 
IL 
3 AluI 10.8 ± 0.8
a
 1.76 ± 0.20
a
 0.76 ± 0.05
a
 
14  9.6 ± 1.7
a
 1.83 ± 0.16
a
 0.81 ± 0.02
a
 
21  10.8 ± 0.8
a
 1.90 ± 0.11
a
 0.80 ± 0.03
a
 
28  8.9 ± 1.8
a
 1.43 ± 0.24
b
 0.65 ± 0.09
b
 
     
3 MspI 12.4 ± 1.2
a
 1.76 ± 0.20
a
 0.74 ± 0.05
ab
 
14  9.8 ± 1.3
b
 1.80 ± 0.22
a
 0.78 ± 0.07
a
 
21  9.8 ± 1.7
b
 1.81 ± 0.22
a
 0.78 ± 0.05
a
 
28  7.6 ± 1.3
c
 1.40 ± 0.33
b
 0.65 ± 0.13
b
 
AC 
3 AluI 15.7 ± 3.1
a
 2.23 ± 0.34
a
 0.82 ± 0.08a 
14  19.0 ± 3.3
a
 2.55 ± 0.15
b
 0.90 ± 0.02
b
 
21  21.7 ± 5.0
a
 2.72 ± 0.22
b
 0.91 ± 0.02
b
 
28  18.6 ± 2.5
a
 2.44 ± 0.20
ab
 0.87 ± 0.03
ab
 
     
3 MspI 15.7 ± 2.9
a
 2.21 ± 0.17
a
 0.83 ± 0.03
a
 
14  20.5 ± 1.8
b
 2.60 ± 0.06
b
 0.90 ± 0.01
b
 
21  23.0 ± 4.5
b
 2.78 ± 0.20
b
 0.92 ± 0.02
b
 
28  15.4 ± 4.3
a
 2.26± 0.35
a
 0.85± 0.06
a
 
Data are presented as means ± SD, n = 12 (FF), n = 10 (FP) and n= 10 (SR). Within same segment and restriction enzyme, means in a 
column without a common letter differ, p < 0.05. AC=Ascending Colon, IL=Ileum. 
1
Shannon index; 
2
Simpson index of diversity.  
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Figure 3.1.  Body weight gain over time. Both VD and CD piglets grew similarly over time. They were not significantly 
different from each other. 
Data are presented as means ± SD, CD= cesarean derived piglets, VD= vaginally derived piglets. 
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Figure 3.2.  Small Intestinal Lactase Activity During Development. Data are presented as means ± SD, There was no effect of 
route of delivery. Lactase activity was highest at d21 and showed similar activity to day 3. Days 14 and 28 also showed similar 
lactase activity and were statistically different from d3 and d21. DD= duodenum, JJ= jejunum, IL=ileum. 
Mean ± SD 
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Figure 3.3.  Small Intestinal Sucrase Activity During Development. Data are presented as means ± SD, There was no effect of 
route of delivery. Sucrase activity increased with time in all segments. The increase in activity was not statistically different 
between days 3 and 14 or between days 21 and 28, but was significantly different between days 14 and 21. DD= duodenum, 
JJ=jejunum, IL=ileum. 
62 
 
             
   
 
 
 
 
 
  
0
200
400
600
800
1000
1200
1400
DD JJ IL
M
ic
ro
m
et
er
s 
Intestinal Section 
3
14
21
Mean ± SD 
Model p<0.05 
Day: p=0.03 
 
a 
a 
a 
ab 
ab 
ab 
b b 
b 
Figure 3.4.  Small Intestinal Villus Height. Data are presented as means ± SD, There was no effect of route of delivery, but 
villus height did statistically differ over time. Villus height was highest at d14 within in each segment of the intestine, and was 
statistically different from d21.  DD= duodenum, JJ=jejunum, IL=ileum. 
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Figure 3.5.  Dissimilarity index generated from cluster analysis from samples of luminal content from ascending colon. 
Cluster analysis displayed 3 clusters at 75% dissimilarity level: d3, d28 and d14/21. Neither VD nor CD piglets form tight 
clusters within same age. VD=vaginally delivered, CD= cesarean derived. Piglet ID numbers are represented as three 
digit code found next to route ID, followed by day.  
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Fig 3.6. Ileal  
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Fig 3.6. Ileal microbiota populations as assessed by qPCR.  Data are presented as means ± SD, Densities of total 
bacteria, Clostridium cluster XIVa and Lactobacillus were stable between d3 and 21, decreased at d28. The 
numbers of Bifidobacterium and Bacteroides did not change over time.  
a 
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Fig 3.7. Ascending colon microbiota populations as assessed by qPCR. Data are presented as means ± SD,  Total bacteria and 
Clostridium cluster XIVa increased between d3 to 14, were stable until d21 and then decreased at d28. Bacteroides increased 
from d3 to 14 and then was stable until d28. Bifidobacterium was stable prior to weaning, then increased at d28. Lactobacillus 
was stable during the sucking period and decreased after weaning. 
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Chapter 4 
Route of Delivery and Prebiotics: Effects on Intestinal Structure, Function, and Immune 
Development 
 
ABSTRACT 
Breast milk is considered the optimal form of nutrition for the human infant, but by 6 
months postpartum, approximately 60% of infants are being formula-fed (CDC, 2011).  Many 
infants who are receiving formula as their primary of source of nutrition are deprived of  
beneficial compounds naturally existing in human milk. One of the groups of bioactive 
components is the human milk oligosaccharides (HMO). This complex group of structures has 
many beneficial effects on the infant including promoting the growth of Bifidobacterium, acting 
as anti-adhesive and anti-microbial factors against pathogens, modulating immune development, 
and perhaps even providing nutrients for brain development (Bode, 2012). Prebiotics are 
commonly being added to infant formula to mimic these naturally occurring HMOs.  
In addition to increasing rates of formula feeding, the proportion of infants being born by 
cesarean section is also on the rise with rates being approximately 30% in the US (Hamilton, 
2009; Betrán, 2007; Mayor, 2005). Route of delivery at birth can influence colonization of 
intestinal microbiota. Vaginally-delivered infants acquire microbes from their mother upon 
passage through the vaginal canal, while cesarean-derived infants obtain more microbes from the 
environment (Biasucci et al, 2008, Dominguez-Bello et al, 2010).  The microbes that colonize 
the newborn intestine influence other functions of the gut, including immune development 
(Mshviladadze and Neu, 2010).  
Herein, the effect of route of delivery and prebiotics on intestinal development, 
immunity, and microbial development was examined. In an attempt to represent what naturally 
occurs in human milk, a combination of two prebiotics were used: polydextrose (PDX) and short 
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chain fructooligosaccharides (scFOS). This chapter will focus on the interactions between route 
of delivery and early nutrition on intestinal development and immunity. We hypothesized that 
adding prebiotics to formula will modulate microbial, intestinal, and immune development so 
that formula+prebiotic piglets will have similar outcomes to sow reared piglets when compared 
to formula fed. Microbial colonization was determined by Dr. Mei Wang, a postdoctoral fellow 
in the Donovan laboratory and will not be presented herein.   
Piglets (n = 64) born by either vaginal (VD: n=37) or cesarean delivery (CD: n=27) were 
allocated to three experimental groups: 1) sow-reared (SR; n=20); 2) formula-fed (FF; n=24) or 
3) formula with prebiotics (FP: n =20).  FF and FP piglets were fed a non-medicated sow milk 
replacer (Advance Baby Pig LiquiWean, Milk Specialties, Dundee, IL). Piglets in FF and FP 
groups were obtained by randomizing 44 piglets (n = 22 per delivery mode) from 5 litters. The 
remaining piglets (VD: n = 15; CD: n = 5) formed the SR group. Sow-reared piglets were nursed 
by two sows throughout the study. Polydextrose (Danisco, Copenhagen, Denmark) and scFOS 
(GTC Nutrition, Golden, CO) were added at 2 g/L each when the formula was prepared.  
 The study duration was 14 days with a collection time point at d7 and d14. Blood and 
pieces of duodenum, jejunum, and ileum were frozen or fixed in Bouins solution for future 
analysis. Dissacharidase and peptidase enzymes were examined in both jejunal and ileal tissues. 
In the jejunum, neither day nor diet had an effect on lactase activity, but day had an effect on 
sucrase activity, with d14 piglets having higher activity than d7. In the ileum, both day 
(p<0.0001) and diet (p<0.0001) affected lactase activity, with FF piglets having highest lactase 
activity followed by FP piglets, and then SR. Lactase activity was also higher at d14 than d7. 
Ileal sucrase activity was also impacted by both day (p<0.0001) and diet (p<0.0001) with FF 
piglets having higher sucrase activity than both FP and SR piglets and activity was higher at d14 
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compared to d7. Aminopeptidase (APN) was measured in both jejunum and ileum, and 
Dipeptidylpeptidase IV (DPPIV) was measured in jejunum and ileum, as well as serum. In the 
jejunum, both day (p=0.0023) and diet (p=0.0003) were significant with d7 piglets having higher 
APN activity than d14. Both FF and FP piglets had higher APN activity compared to SR. In 
ileum, APN also had both day (p=0.047) and diet (p<0.0001) effects with FF piglets having 
significantly higher activity than FP and SR. Jejunal DPPIV showed effects of diet (p<0.0001) 
with FF piglets having higher activity than FP and SR. In ileum, both diet (p<0.0001) and day 
(p=0.0182) had effects with FF piglets having higher activity than FP and SR. There were no 
significant effects in blood.  
Ileal sections were stained for CD3+ T-lymphocyte populations. There was an effect of 
diet (p=0.0085) and day (p<0.0001) on population of CD3+ cells in the ileum. All groups had 
significantly more CD3+ cells at d14 compared to d7 and SR had significantly more cells 
compared to FF with FP being intermediate. Ileal cytokine expression was measured to evaluate 
Th1, Th2 and Treg cytokine expression. There were no differences between diet or day for this 
parameter.  
In summary, route did not have an effect on intestinal structure or function, cytokine 
secretion, or CD3+ cell populations in the intestine. The prebiotics, however, did result in some 
effects with peptidase activity in both the jejunum and ileum as well as with CD3+ cell staining 
in the ileum.  Formula+prebiotic piglets had more similar overall intestinal peptidase activity to 
SR piglets compared to FF. The addition of the prebiotic may have helped to modulate this 
result. However, FP piglets had significantly lower CD3+ cell expression in the ileum compared 
to SR.  While the prebiotic creates similar effects to breast milk in some arenas, it still is not a 
complete replacement.  
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Introduction 
 
Breast milk is considered the optimal form of nutrition for the human infant, but by 6 
months postpartum, approximately 60% of infants are being formula-fed (CDC, 2011). Human 
milk is a very complex food that contains bioactive and immune-modulating compounds in 
addition to its macro- and micronutrient components (Bode, 2012).  Many infants who are 
receiving formula as their primary of source of nutrition are deprived of these beneficial 
compounds naturally existing in human milk. One of the groups of bioactive components is the 
human milk oligosaccharides (HMO). This complex group of structures has many beneficial 
effects on the infant including promoting the growth of Bifidobacteriium, acting as anti-adhesive 
and anti-microbial factors, modulating immune development, and perhaps even providing 
nutrients for brain development (Bode, 2012). Prebiotics, or “a selectively fermented ingredient 
that allows specific changes, both in the composition and/or activity in the gastrointestinal 
microflora, that confers benefits upon host well-being and health” (Gibson et al. 2004; 
Roberfroid, 2007), are commonly being added to infant formula to mimic these naturally 
occurring HMOs.  
In addition to increasing rates of formula feeding, the proportion of infants being born by 
cesarean section is also on the rise with rates being approximately 30% in the US (Hamilton, 
2009; Betrán, 2007; Mayor, 2005). Route of delivery at birth can influence colonization of 
intestinal microbiota. Vaginally-delivered infants acquire microbes from their mother upon 
passage through the vaginal canal, while cesarean-derived infants obtain more microbes from the 
environment (Biasucci et al, 2008, Dominguez-Bello et al, 2010).  The microbes that colonize 
the newborn intestine influence other functions of the gut, including immune development 
(Mshviladadze and Neu, 2010).  
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Herein, the effect of route of delivery and prebiotics on intestinal development, 
immunity, and microbial development was examined. In an attempt to represent what naturally 
occurs in human milk, a combination of two prebiotics was used: polydextrose (PDX) and short 
chain fructooligosaccharides (scFOS). Polydextrose is a randomly polymerized glucose 
oligosaccharide with 12 degrees of polymerization (DP) on average. It is generally recognized as 
safe (GRAS) for the human food supply and is often found in foods as a fat, sugar, or starch 
replacer. It has been shown to exhibit prebiotic properties and beneficial effects on the gut (Jie et 
al, 2000; Peuranen et al, 2004; Probert et al, 2004; Makivuokko et al, 2005).  Short chain 
fructooligosaccharides are naturally occurring in several foods such as leek, asparagus, chicory, 
garlic, Jerusalem artichoke, banana, oats, and soybeans and has a DP between 3-10.  It also is 
GRAS and is usually isolated from one of the foods listed above to be added to foods to increase 
their fiber content (Raninen et al, 2010). scFOS is rapidly fermented in the gut, while the 
fermentation of PDX is much slower (Raninen et al, 2010). In this study, PDX was added not to 
add fiber to the formula, but to help mimic the naturally occurring human milk oligosaccharides 
in conjunction with scFOS.  
Piglets were used in this study as a model for the human infant, as they have been found 
to have more similar gastrointestinal and immune function to humans in comparison to rodents 
(Guilloteau et al., 2010). This chapter will focus on the interactions between route of deliver and 
early nutrition on intestinal development and immunity. We hypothesized that that adding 
prebiotics to formula would modulate microbial, intestinal, and immune development so that 
formula+prebiotic piglets will have similar outcomes to sow reared piglets when compared to 
formula fed.  
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Materials and Methods 
 
Animals and housing 
All animal care and experimental procedures were in accordance with the National 
Research Council Guide for the Care and Use of Laboratory Animals and were approved by the 
Institutional Animal Care and Use Committee at the University of Illinois. Piglets (n = 64) born 
from 7 sows by either vaginal (VD: n=37) or cesarean delivery (CD: n=27) were allocated to 
three experimental groups: 1) sow-reared (SR; n=20); 2) formula-fed (FF; n=24) or 3) formula 
with prebiotics (FP: n=20).  FF and FP piglets were fed a non-medicated sow milk replacer 
(Advance Baby Pig LiquiWean, Milk Specialties, Dundee, IL, Table 4.1). Piglets in FF and FP 
groups were obtained by randomizing 44 piglets (n = 22 per delivery mode) from 5 litters. The 
remaining piglets (VD: n=15; CD: n=5) formed the SR group. Sow-reared piglets were nursed by 
two sows throughout the study. Formula (183 g/L) was provided to FF and FP groups at a rate of 
360 mL/kg body weight divided equally into five feedings per day. Polydextrose (PDX; Danisco, 
Copenhagen, Denmark) and short chain fructooligosaccharides (scFOS; GTC Nutrition, Golden, 
CO) were added at 2 g/L each when the formula was prepared. FF and FP piglets self-fed from a 
nipple that was connected to an enteral nutrition bag that contained the diets (Houle et al., 1997). 
A tray located under the nipple collected any spillage, allowing for accurate determination of 
formula and prebiotic intake. To provide passive immunity, porcine serum obtained from 
pregnant sows was administered orally to piglets in FF and FP groups as follows: 4mL/kg at 
birth, 5mL/kg 12 hours postpartum, and 10mL/kg 22 hours postpartum (Siggers et al., 2008). FF 
and FP piglets were housed individually in metabolism cages with 12 h light/dark cycle as 
previously described (Houle et al., 1997). Room temperature was maintained at 25°C with 
supplemental heat was provided through of radiant heaters suspended above the cages to 
maintain a local temperature between 30 to 32°C. Piglets were weighed each morning and 
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monitored three times per day for general health.  Stool consistency was evaluated daily. The 
following scale was used: 1=Firm/No Diarrhea, 2=Stiff-flowing, 3=Easy-flowing/loose, 
4=Watery/diarrhea, 5=Severe diarrhea.   
Cesarean Section 
The surgical procedure was conducted as described in Chapter 3.   
 
Sample collection 
Samples were collected on postnatal d7 and d14. Piglets were fed one tenth of their daily 
allotment of formula 2h before sample collection. Piglets were first sedated with Telazol (3.5 
mg/kg BW each Tiletamine HCl and Zolazepam HC, Pfizer Animal Health, Fort Dodge, IA). 
After sedation, blood was collected by cardiac puncture into non-coated Vacutainer tubes (BD 
Biosciences, Franklin Lakes, NJ) for serum isolation. Piglets were then euthanized by an 
intravenous injection of sodium pentobarbital (72 mg/kg BW Fatal Plus, Vortech 
Pharmaceuticals, Dearborn, MI). The small intestine was excised from the pyloric sphincter and 
the ileocecal valve, and its length was measured. The intestine was cut at 10 and 85% from the 
proximal end to give three segments corresponding to the duodenum, jejunum, and ileum, 
respectively, on the basis of distances extrapolated from Houle et al. (1997). The large intestine 
was isolated and separated into cecum and colon at the cecocolic junction. The colon was further 
divided equally into ascending, transverse and descending colon. The segments were flushed 
with ice-cold phosphate buffered saline and weighed. Intestinal and colonic segments were 
frozen at -80C for RNA isolation, and preserved in Bouin’s solution for immunohistochemistry.  
Remaining intestinal tissue was opened longitudinally and gently scraped with a microscope 
slide to remove and collect the mucosal lining, then frozen in -80C for subsequent analysis.   
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Mucosal Protein and Disaccharidase Activity  
Mucosal homogenates were prepared and protein content, lactase and sucrase activities 
were determined as described in Chapter 3 
 
Peptidase Activity 
Peptidase activity was measured according to method of Sangild et al. (2002).  Frozen 
mucosa (0.2 g) was homogenized into 2 mL of 1.0 % Triton X-100 (Fisher Scientific, Pittsburgh, 
PA). The activities of APN and  DPPIV were quantified using the substrate solutions 2.5 mM L-
ananin-4-nitro-analid-hydrochloride (Bachem Bioscience, Inc., King of Prussia, PA) in 50 mM 
Trizma base buffer (pH=7.3) and 3mM Glycyl-prolyl-p-nitroanalide p Tosylate (Bachem 
Bioscience, Inc.) in 50 mM Trizma base buffer (pH=8.0), respectively. Using a 
spectophotomoter, the catalytic activity of the enzymes was measured kinetically over 3 minutes 
at an absorbance of 405 nanometers. To calculate enzyme activity, the Beer and Lambert Law 
was incorporated into an equation multiplying the slope with the dilution factor (range of 1:5-
1:10) and a constant (4.33523). Peptidase enzymes were expressed in units of enzyme per gram 
of tissue (U/g). 
 
RNA Extraction and Real Time Quantitative (RT qPCR)  
 
Frozen ileal sample (0.05-0.1 mg) was homogenized with 1 mL of TRIzol reagent 
(Invitrogen Life Technologies, Grand Island, NY). Samples were incubated at room temperature 
for 5 min and then transferred to 1.5 mL microcentrifuge tube and then centrifuged at 12,000 g at 
4°C for 15 min. The aqueous phase was transferred to a new tube and then 0.5 mL isopropyl 
alcohol and incubated for 10 min at room temperature. Samples were then re-centrifuged and the 
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supernatant removed. The pellet was washed with 75% ethanol and then centrifuged at 7,500 g 
for 5 min and then allowed to air dry. DEPC water was added and the pellet dissolved. RNA 
content was quantified using Nano Drop (Thermo Scientific, Wilmington, DE) and then 
appropriate dilutions will be made and mRNA samples made into cDNA using Reverse 
Transcriptase (RT) Reaction with a master mix of 10X RT buffer (2µl/ sample), 25X dNTP mix 
(0.8µl/sample), 10X Random Primers (2µl/sample), MultiScribe Reverse Transcriptase 
(1µl/sample), RNase Inhibitor (1µl/sample), and Nuclease Free Water (3.2µl/sample) (all 
components supplied by Invitrogen, Carlsbad, CA).  The master mix (10µl) was aliquoted to 
each sample and then run using a thermocycler (Eppendorf Mastercycler Gradient, Ocala, FL) 
with the following program: 25°C for 5 min, 37°C for 2 h, and then 85°C for 5 sec, followed by 
4°C until the samples were removed.  qPCR was performed on the cDNA samples.  β-actin was 
used as a standard and interleukin-12 (IL-12), interleukin-10 (IL-10), and transforming growth 
factor-β (TGF- β) were used to represent Th1, Th2, and Treg cytokines, respectively.  
 
Immunohistochemistry 
Bouins’-fixed, paraffin-embedded ileum samples were sliced to approximately 5µm with 
a microtome, mounted on slides, and stained with CD3+ antibody at the Veterinary Medicine 
Histology Lab at the University of Illinois at Urbana-Champaign. Slides were then scanned using 
the Nanozoomer Virtual Microscopy system (Hammamatsu, Bridgewater, NJ). The Axiovision 
(Zeiss) program was used to quantify positively stained cells. Only cells within a 100 
micrometer
2 
area of the villi of the ileum were selected and quantified.  
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Statistical Analysis 
Statistical analysis was first performed using one-way ANOVA according to the General 
Linear Model (GLM) procedure of SAS (SAS Institute, Cary, NC). Day, diet, mode of delivery, 
and their respective interactions were used in the statistical model. When no significant effects 
were detected for interactions, these were removed from the statistical model. When significant 
differences were detected within the treatment, least significant difference test was used to 
identify differences between individual means. For all the comparisons, statistical significance 
was set at p ≤ 0.05 and data are expressed as mean ± S.D.  
For body weight gain, the Mixed Procedure of SAS for repeated measures was used. Day, 
diet, mode of delivery and their respective interactions were used in the statistical model. When 
no significant effects were detected for interactions, these were removed from the statistical 
model. When significant differences were detected within the treatment, least significant 
difference test was used to identify differences between individual means. For all the 
comparisons, statistical significance was set at p ≤ 0.05 and data are expressed as mean ± SD.  
 
Results 
There was no effect of route of delivery on any of the following results, so it was 
eliminated from model statements. 
 
Weight gain and stool consistency 
Piglets were weighed daily. All piglets gained weight similarly, independent of diet group 
(Figure 4.1). Average weights from day 7 and day 14 are represented in Table 4.2.  Stool 
consistency did not differ between diet groups (Table 4.2).  
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Intestinal weight and length 
Intestinal weight and length were measured at time of sample collection. There was in an 
increase in intestinal weight from day 7 to day 14 (Table 4.2).  At day 14, diet affected intestinal 
weight with FF and FP piglets having similar intestinal weight, but both groups being 
significantly different from SR piglets (P<0.05).  
  
Disaccharidase Activity 
Lactase activity was measured in the jejunum and ileum of d7 and d14 piglets. There 
were no significant effects of day or diet on jejunal lactase activity (Table 4.3). In the ileum, 
both day (p<0.0001) and diet (p<0.0001) were significant. Formula fed piglets had the highest 
lactase activity followed by FP piglets, and then SR. Lactase activity at d14 was also 
significantly higher than at d7 within the ileum (Figure 4.2). 
Sucrase activity was measured in the jejunum and ileum of d7 and d14 piglets. In the 
jejunum, day was the only significant factor (p<0.0001) with d14 having higher sucrase activity 
compared to d7 (Table 4.2). In the ileum, both diet (p<0.0001) and day (p<0.0001), as well as 
their interaction (p=0.01) significantly impacted sucrase activity. Formula fed piglets had higher 
lactase activity than both FP and SR piglets and d14 sucrase activity was higher than d7 in the 
ileum (Figure 4.3).  
 
Peptidase 
Aminopeptidase N activity in the jejunum was affected by both day (p=0.0023) and diet 
(p=0.0003) but there was no significant interaction between day and diet (Figure 4.4),. Day 7 
piglets from all diet groups had a more APN activity compared to d14 piglets. Formula fed and 
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FP piglets had significantly higher APN activity compared to SR piglets.  In the ileum, both diet 
(p<0.0001) and day (p=0.047) had a significant effect (Figure 4.5). Formula-fed piglets had 
significantly different APN activity compared to both FP and SR piglets. 
 Dipeptidylpeptidase IV activity in the jejunum was affected by diet (p<0.0001) (Figure 
4.6). Formula-fed piglets had significantly higher activity than FP and SR piglets. In the ileum, 
diet (p<0.0001) and day (p=0.0182) were both significant factors in DPPIV activity (Figure 4.7). 
Formula-fed piglets were significantly different from both FP and SR piglets, both of who were 
similar to each other.  In the blood, diet only showed a trend (p=0.06) (Figure 4.8). SR piglets 
had the most DPPIV activity followed by FP and FF piglets.  
 
CD3+ Cell Staining and Quantification 
T-lymphocytes were detected in ileal sections by immunohistochemistry and quantified 
relative to villus area (100 mm²).  There was an effect of diet (p=0.0085) as well as day 
(p<0.0001) on CD3+ cells (Figure 4.9). All diet groups had significantly more CD3+ cells at day 
14 compared to day 7 and SR had significantly more cells than FP piglets, with FF piglets being 
intermediate. There was no interaction between the two terms. 
 
Ileal Cytokine mRNA Expression  
The expression of cytokines representative of T-lymphocyte subpopulations was assessed 
by RT-qPCR.   There were no significant differences between day or diet in Th1 (IL-12), Th2 
(IL-10) and Treg (TGF-β) cytokine expression (Table 4.4).  
 
 
78 
 
Discussion 
Infants fed formula as their source of nutrition do not benefit from the immune-
modulating components found naturally occurring in breast milk. These naturally-occurring 
substances include HMO, which have prebiotic activity (Bode, 2012). To mimic the activity of 
HMO, prebiotics are now a common addition to infant formulas (Bode, 2012).  In an attempt to 
represent the varied HMO structures naturally found in human milk, many companies add more 
than one prebiotic to their infant formula. To this end, this study tested a novel combination of 
prebiotics: PDX and scFOS. Our goal was to investigate how this combination of prebiotics, in 
addition to route of delivery, would affect intestinal function as well as several measures of 
immune development.  Route of delivery did not have a significant effect on the parameters of 
the study, so it was removed from the statistical model and outcomes focused on the impact of 
prebiotics and development.  
Intestinal function was measured by evaluating dissacharidase and peptidase activity 
within the jejunum and ileum. Our results show increased ileal lactase activity was increased at 
d14 compared to d7. This follows normal patterns for lactase activity within the intestine of 
growing piglets (Manners and Stevens, 1972). Our results also show that sucrase activity was 
higher at d14 then d7 in both the jejunum and ileum. This also follows normal patterns for 
sucrase expression (Adeola and King, 2006) within the developing piglet. However, diet 
differences regarding ileal sucrase activity in 14-do piglets were observed. Formula-fed piglets 
had the highest sucrase activity, followed by FP piglets and finally SR piglets. This suggests that 
the prebiotics may be causing the FP piglets to have sucrase activity more similar to SR.   
Immunity was measured by investigating DPPIV expression within serum, evaluating 
CD3+ cells numbers as well as measuring cytokine gene expression within the ileum.  DPPIV, 
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while in the gastrointestinal tract is brush border hydrolase used in protein digestion (Marion et 
al, 2005). In the blood, DPPIV/CD26 has been shown to be expressed on activated T-
lymphocytes (Lojda, 1977) and is used in the regulation of differentiation and growth of T-
lymphocytes (Dang et al, 1990; Ansorge et al, 1991; Torimoto et al, 1991). Activated T-
lymphocytes can differentiate into Th1, Th2 or Th17 cells that will in turn secrete cytokines that 
facilitate an immune response. All three diet groups showed similar levels of circulating 
DPPIV/CD26.  When we investigated cytokine gene expression between all diet groups, we did 
not find any significant differences between diet groups. These two results imply that diet did not 
affect cytokine secretion, however, there were differences in the number of ileal CD3+ cells 
amongst diet groups at d14. There were no differences between diet groups at d7, but this could 
be because the piglet’s gut was still immature. At d14, we see that SR and FF piglets have more 
ileal CD3+ cells compared to the FP group. It is unknown at this time if the CD3+ cells are 
CD4+ or CD8+ T-lymphocytes. This needs to be investigated further, as this may help us better 
understand the role of diet in T-lymphocyte differentiation as well as its concomitant role with 
other immune related parameters such as B-lymphocyte development. 
In summary, route did not have an effect on intestinal structure or function, or cytokine 
secretion or CD3+ cell populations in the intestine. The prebiotics, however, did show some 
effects with peptidase activity in both the jejunum and ileum as well as with CD3+ cell staining 
in the ileum.  Formula+prebiotic piglets had more similar overall intestinal peptidase activity to 
SR piglets compared to FF. The addition of the prebiotic may have helped to modulate this 
result. However, FP piglets had significantly lower CD3+ cell expression in the ileum compared 
to SR.  While the prebiotic creates similar effects to breast milk in some arenas, it still is not a 
complete replacement.   
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Component Per kg Powder Reconstituted (g/L) 
  
Lactose (g) 479.0  87.0  
Crude Protein (g) 250.0 45.8  
Crude Fat (g) 130.0  23.8  
Ash (g) 66.0 12.1 
  
Amino Acids   
Arginine (g) 6.7  1.2  
Histidine (g) 4.7  0.9  
Isoleucine (g) 14.5  2.7  
Leucine (g) 25.0 4.6  
Lysine (g) 22.  4.1  
Methionine (g) 5.0  0.9  
Phenylalanine (g) 8.2  1.5  
Threonine (g) 18.1  3.9  
Tryptophan (g) 6.9  1.3  
Valine (g) 14.6  2.7  
  
Vitamins    
Vit B1 (mg) 8.5 0.2 
Vit B2 (mg) 27.3 5.0 
Vit B6 (mg) 2.0 0.4 
Vit B12 (µg) 73.7 13.7 
Vit A (KIU) 44.0 8.1 
Vit D (KIU) 12.1 2.2 
Vit E (IU) 33.2 6.1 
Vit C (mg) 121.9 22.3 
Choline (g) 1.8 0.32  
Pantothenic Acid (mg) 61.6 11.3 
Niacin (mg) 47.4 8.7 
Folic Acid (mg) 3.35 0.61 
Biotin (mg) 0.26 0.05 
  
Minerals and Electrolytes   
Calcium (g) 6.2 1.1 
Chloride (g) 8.1 1.48 
Cobalt (mg) 1.23 0.23 
Table 4.1.  Composition of Sow Milk Replacer Formula. 1 
1 
Advance Baby Pig LiquiWean, Milk Specialties, Dundee, IL. 
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Body Weight 
(kg) 
Intestinal Weight 
(g/kg) 
Intestinal Length 
(cm/kg) 
*Stool Consistency 
Score 1-5 
Day 7         
FF 1.59 ± 0.27 76.0 ± 29.1 299.7 ± 37.9 1.06 ± 0.15 
FP 1.49 ± 0.33 91.5 ± 13.1 328.5 ± 40.9 1.29 ± 0.28 
SR 1.78 ± 0.35 74.3 ± 1.8 293.1 ± 36.1 1.01 ± 0.04 
Day 14     
FF 2.27 ± 0.20 167.6  ± 33.8 281.4 ± 18.5 1.07 ± 0.11 
FP 2.19 ± 0.40 172.6  ±24.8 283.2 ± 25.4 1.13 ± 0.16 
SR 2.31 ± 0.51 141.7 ± 26.8 287.1 ± 51.0 1.03 ± 0.05 
Table 4.2.  Body weight, intestinal weight, intestinal length, and stool consistency. There were no significant differences 
between route of delivery or diet groups within each time point. 
Values are expressed as Mean ± SD; FF= Formula fed, FP= Formula +Prebiotic, SR= Sow reared. 
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P-value 
 
Diet D7 D14 Day Diet Day*Diet 
Lactase 
FF 452.43 ±187.33 589.57 ± 110.1 
0.5192 0.106 0.491 FP 673.48 ± 181.14 440.46 ± 146.11 
SR 333.71 ± 134.29 442.88 ± 238.58 
Sucrase 
FF 18.37 ± 9.48
b
 155.95 ± 87.29
a
 
<0.0001 0.5611 0.126 FP 37.29 ± 27.71
b
 129.15 ± 65.16
a
 
SR 47.71 ± 23.04
b
 90.36 ± 47.99
a
 
Table 4.3:  Jejunal dissacharidase activity. There were no effects of route on this parameter. Lactase activity was not different 
between diet groups. Sucrase activity was not affected by route, or diet, but was affected by day Units of measure are 
mmol/glucose/g protein/min..  
Values are expressed as Mean ± SD. FF= Formula fed, FP= Formula +Prebiotic, SR= Sow reared.  Means in each row without a 
common letter differ p≤0.05. 
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Table 4.4. Cytokine expression in ileum. Expression of data is in fold change relative to the SR group.  There were no 
significant differences between diet groups for this measure.  
Values are expressed as Mean ± SD. 
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Figure 4.1. Weight gain over time. Data are expressed as Mean ± SD. Weight gain did not statistically differ between diet groups.  
F= Formula fed, FP= Formula +Prebiotic, SR= Sow-reared.  
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Figure 4.2. Ileal lactase activity. Data are expressed as Mean ± SD.  Different letter superscripts differ at p≤0.05. Lactase activity was 
significantly higher at d14 compared to d7. FF piglets had the highest lactase activity, followed by FP piglets and then SR. F= 
Formula fed, FP= Formula +Prebiotic, SR= Sow Reared.  
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Figure 4.3. Ileal sucrase activity. Data are expressed as mean ± SD. Different letter superscripts differ at p≤0.05.  Sucrase activity 
was significantly higher at d14 compared to d7. FF piglets had the highest sucrase activity, followed by FP piglets and then SR. 
F= Formula fed, FP= Formula +Prebiotic, SR= Sow Reared. 
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Figure 4.4. Jejunal Aminopeptidase N (APN) activity.  Date are expressed as mean ± SD. Different letter superscripts differ at 
p≤0.05. APN activity was significantly higher at d7 compared to d14. FF and FP piglets had higher APN activity compared to SR. 
F= Formula fed, FP= Formula +Prebiotic, SR= Sow Reared. 
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Figure 4.5. Ileal  Aminopeptidase N (APN) activity. Data are expressed as mean ± SD. Different letter superscripts differ at p≤0.05. 
APN activity was significantly higher at d7 compared to d14. FF and FP piglets had higher APN activity compared to SR. F= 
Formula fed, FP= Formula +Prebiotic, SR= Sow Reared. 
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Figure 4.6. Jejunal  Dipeptidylpeptidase IV ( DPPIV) activity. Data are expressed as mean ± SD. Day did not have an effect. FF 
piglets had highest DPPIV activity, followed by FP, and then SR piglets.  F= Formula fed, FP= Formula +Prebiotic, SR= Sow 
Reared. 
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Figure 4.7. Ileal  Dipeptidylpeptidase IV (DPPIV) activity. Data are expressed as mean ± SD. DPPIV activity was significantly 
higher at d14 compared to d7. FF piglets had higher DPPIV activity compared to both FP and SR groups.  F= Formula fed, FP= 
Formula +Prebiotic, SR= Sow Reared. 
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Figure 4.8. Serum Dipeptidylpeptidase IV/ Cluster of Differentiation 26 (DPPIV/CD26)  activity. Data are expressed as mean ± 
SD.  DPPIV/CD26 activity was not significantly different between diet groups. F= Formula fed, FP= Formula +Prebiotic, SR= 
Sow Reared. 
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Figure 4.9. Ileal CD3+ T-lymphocytes detected by immunohistochemistry. Data are expressed as mean ± SD.  Different letter 
superscripts differ at p≤0.05.  F= Formula fed, FP= Formula +Prebiotic, SR= Sow Reared. 
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Chapter 5 
Combined Feeding and Prebiotics: Effects on Immune Development and Colonic Gene 
Expression in the Neonatal Pig 
 
ABSTRACT 
Breastfeeding is considered to be the most optimal form of nutrition for a neonate. 
Immediately after birth, 77% of women initiate breastfeeding but by 6 months post-partum, only 
43% are still breastfeeding with only 13% being exclusively breastfed. The remaining 30% are 
using formula feeding supplemented with breast milk or they are “combined fed” (CF) (CDC, 
2009). Women choose not to continue breastfeeding for many reasons, including low milk 
production, discomfort while breastfeeding, or short maternity leave (Thulier and  Mercer, 2009). 
There are many differences found between exclusively breastfed and exclusively formula fed 
infants. Breast milk contains many different bioactive compounds, such as: human milk 
oligosaccharides, antibodies, immune cells, and cytokines which may be modulating these 
differences (Bottcher et al, 2003).  
The third aim of this dissertation focused on the effects of combined feeding and 
prebiotics on immune response and the colonic transcriptome. We developed a novel piglet 
model to investigate these effects. Newborn piglets were randomized into 5 groups: sow-reared 
(SR), formula fed (FF), formula+prebiotic (FP), combined fed (CF), and combined fed 
+prebiotic (CP) (n=6 per group). SR remained with the sow 24h/day and FF/FP piglets were fed 
a sow milk replacer with or without prebiotics (GOS; Inulin; 2g/L each). CF/CP piglets were 
sow-reared for 5d and were then rotated between the sow and respective formula feeding group 
every 12h. On d21, piglets were intraperitonealy injected with 10ug/kg body weight of LPS. 
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Four hours after infection, blood, mesenteric lymph node (MLN), spleen (SPL), and ascending 
colon were collected and analysis performed. 
  Immunity was tested by investigating both immune cell profiles and macrophage 
activation. T-cells, B-cells, dendritic cells, and macrophages were isolated, stained, and read 
using a flow cytometer. In blood, SR showed significantly (p<0.0001) lower percentage of 
CD4+CD8- T-helper cells, while in the MLN they were intermediate between CP (p=0.0264) 
and all other diet groups. However, SR had a significantly (p<0.0001) higher percentage of B-
cells compared to all other diet groups in blood. There were no significant differences between 
diet groups with dendritic cell or macrophage populations.  Both acute phase response pro-
inflammatory cytokines, IL-6 and TNF-α, were measured using ELISA. FF piglets had a much 
higher IL-6 response than both CF and SR diet groups. Strong responses of inflammatory 
cytokines in response to pathogens, and in particular to LPS, have been linked to an increase for 
sepsis (Lakhani and Bogue, 2003). There was no significant difference in immune reaction to 
TNF-α. In addition, macrophage activation pathways, classical versus alternative, were also 
tested in both MLN and SPL tissue. Both nitric oxide synthase (classical) and arginase 
(alternative) enzyme activities were evaluated. There were no significant differences between 
diet groups when measuring nitric oxide synthase activity, but CP group did have significantly 
(p<0.0001) higher expression of arginase in MLN compared to all other diet groups. Combined 
feeding with prebiotic did have some effect in response to immune stimulus and seemed to 
encourage an anti-inflammatory immune profile as evidenced by the significantly higher 
arginase production which is caused by secretion of anti-inflammatory cytokines: IL-4, IL-10, 
IL-13 (Dewals et al, 2010).  
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Gene expression was assessed using a porcine microarray (Agilent). Among 25,273 
probes, 449 were differentially expressed (FDR p<0.2). Bioinformatic analyses using MetaCore, 
revealed that the most significant GeneGo pathway maps were, related to apoptosis, 
carbohydrate metabolism, lipid metabolism and neuronal pathway synthesis. CF and SR may 
have more similar gene expression with lipid and carbohydrate metabolism, and apoptosis. FF 
and CF have more similar gene expression with glucose transport.  More research is needed in 
this area to see how these differences will affect future health outcomes.  
Combined feeding with or without prebiotics influenced immunity and gene expression. 
Our data suggest that neonates fed both mother’s milk and formula display differences in 
immune development and gene expression relative to those fed exclusively mother’s milk or 
formula. 
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Introduction 
Breastfeeding is the optimal form of nutrition for the human infant.  The breastfeeding 
initiation rate in the U.S. is currently at 77%, however, the incidence of exclusive breastfeeding 
declines over the first few months postpartum, reaching ~43% at 6 months of age (CDC, 2011).  
Some of these infants are fully weaned to formula, while~30% of infants receive breast milk 
supplemented with formula by 6 months postpartum (CDC, 2011). Based on the data in the 2011 
Breastfeeding Report Card (CDC 2011), we estimated that 44% and 24% of infants are 
combined-fed at 6 and 12 months respectively (Figure 5.1). This percentage was determined by 
subtracting the percentange of infants that are exclusively breastfed from the percentage of 
infants receiving any breastmilk (CDC 2011). Mothers choose to supplement formula for a 
multitude of reasons including: the perception of inability to make an adequate amount of milk 
for their infant, short duration of maternity-leave or discomfort while breastfeeding (Thulier and  
Mercer, 2009).   
It is well documented that there are many differences between the exclusively breastfed and 
exclusively formula-fed neonates. Exclusively breastfed neonates have lower rates of morbidity 
and mortality compared to their exclusively formula-fed counterparts (Yoshioka, 1983).  
Exclusive formula-feeding is associated with an increased risk of common childhood ailments 
such as diarrhea and otitis media, or an acute ear infection, which is 100% higher among 
exclusively formula-fed infants compared to exclusively breastfed infants during the first six 
months of life (Ip et al, 2007). Formula feeding is also related to higher risk of developing 
chronic diseases, including asthma, type 2 diabetes, and childhood obesity (Ip et al, 2007). The 
benefits associated with breastfeeding may be partially attributed to the numerous protective 
components found in breast milk that include: antibodies, human milk oligosaccharides (HMO), 
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immune cells and cytokines (Bottcher et al, 2003). These bioactive components influence the 
neonate’s microbial colonization as well as immune system maturation. Formula lacks these 
components, and neonates who are exclusively formula-fed show a different pattern of 
colonization and immune development (Hascoet et al, 2011). Although combination feeding 
(breastmilk and formula) is a common method of infant feeding in the U.S., there is a paucity of 
epidemiological, clinical or basic research on how this method of impacts neonatal intestinal or 
immune development. 
HMOs constitute the third most predominant nutrient of human milk after lactose and 
lipid. These oligosaccharides interact with the resident microbiota and, in turn, the immune 
system. HMO are currently not available in sufficient quantities to supplement to infant formula, 
therefore, prebiotics are commonly used to mimic the biological activities of these naturally 
occurring oligosaccharides found in human milk. Prebiotics are defined by their ability to 
increase beneficial bacteria in the colon and may be responsible for numerous health benefits 
(Gibson and Roberfroid, 1995). There are many different prebiotics available for use in the 
human food supply, two of those being galactooligosaccharides (GOS) and inulin. We utilized 
both of these prebiotics in our study as they are both generally recognized as safe (GRAS) by the 
Food and Drug Administration and GOS is already added to some infant formula.   
It is unknown whether mucosal innate immunity of infants receiving both breast milk and 
infant formula, with or without added prebiotics, more closely resemble their exclusively breast-
fed or formula-fed counterparts or whether these infants establish an intermediate balance 
between the two.  This study aims to fill the gap in knowledge by examining the effects of the 
combined feeding method on neonatal development. We hypothesized that combined fed piglets 
would react more similarly to sow reared piglets after being injected with LPS and both groups 
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would show similar results within our immune parameters, but combined fed piglets would show 
an independent pattern of gene expression compared to the two exclusive groups.  To undertake 
this study, our laboratory recently developed a novel piglet model that simulates combination 
feeding.   
 
Materials and Methods 
 
Animals and Housing 
All animal care and experimental procedures were in accordance with the National Research 
Council Guide for the Care and Use of Laboratory Animals and were approved by the 
Institutional Animal Care and Use Committee at the University of Illinois. The study design is 
shown in Figure 5.2 Newborn piglets (n=44) were allowed to suckle and receive colostrum from 
their mother for 3-4 hours (no more than 4 hours after birth) and were then randomized in one of 
three groups: sow-reared (SR: n=24), formula-fed (FF: n=10), and formula-fed + prebiotic (FP: 
n=10). All FF and FP piglets were orally-administered sow serum for an additional 36 h to 
confer passive immunity. Non-medicated pig milk replacer formula was used for both FF and FP 
groups (Advance Baby Pig Liquiwean: Milk Specialties, Dundee, IL).  FP piglets were fed 
formula containing a mixture of 2 g/L each of GOS and inulin (both from GTC Nutrition, 
Golden, CO) that was added to their daily formula intake.  At day 5, a group (n=16) of the SR 
piglets were randomized into the “combination feeding” group. Combination feeding consisted 
of rotating the piglets between the sow and formula feeding every 12 h.  Combination-fed piglets 
were further randomized to receive formula with (CP: n=8) or without (CF: n=8) prebiotics.  
These piglets remained in this group for the remainder of the study.  All animals were weighed 
daily and body weight of FF, FP, CF, CP piglets were used to determine formula intake using the 
equation of 360 mL/kg/d.  CF and CP piglet only received half of their allotment of formula per 
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day, as they also received nutrition from the sow. In addition, stool consistency and overall 
wellness was assessed as previously described (Correa-Matos et al, 2003).  On d21, all piglets 
were injected IP with 10µg/kg body weight of LPS (Escherichia coli serotype K-235) 2h prior to 
euthanasia.   
 
Sample Collection 
Samples were collected on postnatal d21. Upon termination of the study, piglets were 
first sedated with Telazol (7 mg/kg body weight). After sedation, pigs were euthanized with an 
intracardiac injection of sodium pentobarbital (Fatal Plus: 72 mg/kg body weight). Blood 
samples were collected for immune cell isolation as well as for serum isolation.  Spleen and 
mesenteric lymph nodes (MLN) were collected immediately for immune cell isolation and 
phenotyping.  The small intestine was excised from the pyloric sphincter and the ileocecal valve, 
and its length was measured. The intestine was cut at 10 and 85% from the proximal end to give 
three segments corresponding to the duodenum, jejunum, and ileum, respectively, on the basis of 
distances extrapolated from Houle et al. (1997). The large intestine was isolated and separated 
into cecum and colon at the cecocolic junction. The colon was further divided equally into 
ascending, transverse and descending colon. The segments were flushed with ice-cold phosphate 
buffered saline and weighed. Intestinal and colonic segments were frozen at -80C for RNA 
isolation.  Remaining intestinal tissue was opened longitudinally and gently scraped with a 
microscope slide to remove and collect the mucosal lining, then frozen in -80C for subsequent 
analysis.   
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Isolation of Mononuclear Cells from Peripheral Blood and Immune Tissues  
Peripheral blood mononuclear cells (PBMC) were isolated as described by Boudry and  
colleagues (2007). Briefly, 10 ml of heparinized blood was diluted in 25 ml of RPMI and the 
PBMC were recovered after centrifugation (400 g, 30 min) across a density gradient on 
lymphocyte separation medium (Ficoll-Paque PLUS, GE Healthcare, Uppsala, Sweden) (Boudry 
et al, 2007). The isolated PBMC were placed in culture medium (RPMI; Gibco Invitrogen, 
Grand Island, NY) medium including 20% fetal calf serum (Gibco Invitrogen), 2mM L-
glutamine, 100μg/mL penicillin, 100mg/mL streptomycin, and 2 mM gentamycin). Mononuclear 
cells from MLN and spleen were obtained by dicing each organ sample into small pieces that 
were further dissociated using a gentleMACS Dissociator (Miltenyi Biotec, Bersgisch Gladbach, 
Germany) with 3 incubations at 37C of 30 min each in Hank’s Balanced Salt Solution (HBSS) 
plus Collagenase D (Roche Life Sciences, Indianapolis, IN). The cells were filtered through a 
100μm and 40μm filter (BD Biosciences, Franklin Lakes, NJ) to form a single cell suspension.  
The number of viable cells was assessed by counting after staining with trypan blue (Gibco 
Invitrogen) and reported per mg of tissue (Boudry et al, 2007).  Some cells were frozen for RNA 
extraction and remaining cells were phenotyped by flow cytometry as described below.   
 
Phenotypic Identification of Mononuclear Cells   
On day 21, the phenotypes of mononuclear subpopulations from peripheral blood and 
lymph nodes were monitored by a flow cytometry using a panel of fluorescein (FITC) or 
Phycoerythrin (PE)-labeled mAbs for dendritic cells (DC), macrophages (Mφ), natural killer 
(NK) cells, B-cells, and T-cells and established methods in our laboratory (Thorum, 2011). 
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T-Lymphocytes and Natural Killer Cells: T-lymphocytes were identified by mouse anti-
pig CD4 (FITC, Clone 74-12-4) and mouse anti-pig CD8 (PE, Clone 76-2-11) antibodies (BD 
Biosciences, San Jose, CA) (Boudry et al, 2007).  Ten µl of each antibody were added to 1x10
6
 
cells from each sample.  Samples were incubated for 20 min and then washed twice.  The 
immune cell phenotypes and relative abundances were then assessed by BD™ LSR II flow 
cytometry unit (BD Biosciences).  NK cells were evaluated using percentage of cells identified 
as CD3-CD4-CD8
+
. The relative percentage of T-lymphocyte sub-populations (CD4
+
, CD8
+
), 
single-or double positive (CD4
+
CD8
+
), cells were also evaluated by using FlowJo 7.0 software 
(FlowJo, Ashland, OR).  
B-Lymphocytes: B-lymphocytes were identified using mouse anti-pig CD21 (PE, clone 
BB6-11C9.6, Southern Biotech, Birmingham, AL) and mouse anti-pig MHCII (FITC, clone 
2E9/13, ABD Serotec, Raleigh, NC) antibodies (Boudry et al, 2007).  Ten µl of each antibody 
were added to 1x10
6
 cells from each sample.  Samples were incubated for 20 min and then 
washed twice. The samples were then assessed by flow cytometry unit and the relative 
percentage of B-cells were evaluated as described above.   
Dendritic Cells and Macrophages: DC were identified by mouse anti-pig CD172a 
(Biotin, clone BL1H7, ABD Serotec), mouse anti-pig CD16 (PE, clone G7, AbD Serotec), 
MHCII (FITC, clone 2E9/13, ABD Serotec), and Strep (PECy5, BD Biosciences) (Boudry et al, 
2007).  Mφ were identified by CD172a (Biotin, clone BL1H7, ABD Serotec), CD163 (PeCy5), 
CD14 (FITC, clone 74-12-4) and CD3 (PE) antibodies (BD Biosciences). Ten µl of each 
antibody were added to 1x10
6
 cells from each sample.  Samples were incubated for 20 min and 
then washed twice.  The samples were then assessed by flow cytometry unit and the relative 
percentage of DC and Mφ were evaluated as described above.   
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Serum IL-6 and TNF-α 
Quantikine ELISA kits (R&D Systems, Minneapolis, MN) for IL-6 and TNF-α were used 
to quantify these cytokines in piglet serum.  Blood was centrifuged for 15 min at 4°C at 3200 g. 
Serum was collected and frozen at -80°C until ELISAs were run. Briefly, 50µl of assay diluent 
RD1-63 was added to each well of a 96-well plate.  Sample (50µl) was added to each well and 
mixed gently. The plate was covered and incubated at room temperature for 2h. Each well was 
aspirated and washed 5 times with wash buffer. Porcine TNF-α conjugate or porcine IL-6 
conjugate (100µl) was added to each well and then re-incubated for another 2h. The plate was 
again re-aspirated and washed as stated previously. Substrate solution (100µl) was added and 
incubated for 30 min at room temperature, protected from light, then 100µl of Stop Solution was 
added to each well to end the reaction. Optical density at 450nm was determined using a 
microplate reader (Molecular Devices, Spectra Max M2, Sunnyvale, CA). 
 
Nitric Oxide Production from Isolated Macrophages   
Isolated macrophages from spleen and MLN were plated into a 96-well plate at a 
concentration of 200,000 cells per well.  A standard curve was prepared (0mM-100mM) using 
differing concentrations of double distilled water and sodium nitrite. 100µl of a working reagent 
(24.3 mL double distilled water, 735µl H3PO4, 0.25g sulfonamide, 0.0025g naphthyl-ethyl-
enediamine-dihydrochloride) was added to the cells and then incubated at room temperature for 
15 minutes. Optical density at 450nm was determined using a microplate reader (Molecular 
Devices) and compared to standard curve to estimate amounts of nitric oxide being produced.  
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Arginase Activity in Isolated Macrophages  
This assay was based on the protocol from Mosser and Zhang (2008). Isolated 
macrophages from spleen and MLN were plated into a 96-well plate with a concentration of 
200,000 cells per well. Then, 100 µl Triton 0.1% was added to lyse cells. After cell lysis, 100µl 
of 50mM Tris-HCl, pH 7.5 was added as well as 10µl MnCl2. Samples were transferred to 
safelock tubes and then incubated at 56°C to activate the enzyme. Arginine (100 µl, 0.5M, pH 
9.7) was added and samples incubated for 2 h. Reactions were stopped using 800µl of an acid 
mix of H3PO4, H2SO4, and H2O in a ratio of 1:3:7.  40µl of α- isopentyl-S-thiolodiphosphate (α-
ISPP) 6% was added, the tubes vortexed and then incubated at first at 95°C and then at 4°C for 
30 min each. Samples were transferred to another 96-well plate and then optical density at 540 
nm was determined using a microplate reader (Molecular Devices) and compared to a linear urea 
standard curve. 
 
RNA extraction and Microarray to Measure Gene Expression 
RNeasy Plus Mini Kit (Qiagen, Valencia, CA ) was used to extract RNA from ascending 
colon (AC) tissue to measure gene expression using Porcine Agilent Microarray. Briefly, 30 mg 
of whole AC tissue was homogenized with 600 μl Buffer RLT plus. After complete 
homogenization, the lysate was centrifuged for 3 min, and supernatant was removed and 
transferred to a gDNA eliminator spin column placed inside a 2mL collection tube. The sample 
was centrifuged for 30 sec at 8000 g. The flow-through was saved and the column discarded. 
One volume (600 μl) of Buffer RLT Plus was added and pipetted to mix. Seven hundred μl of 
sample was then transferred to an RNeasy spin column placed in a 2 mL collection tube, then 
centrifuged for 15 sec at 8000 g. The flow through was discarded. Buffer RW1 (700 μl) was 
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added to the RNeasy spin column and centrifuged for 15 sec at 8000 g to the wash spin column 
membrane and the flow-through was discarded. Buffer RPE (500 μl) was then added to the 
RNeasy spin column and centrifuged again for 15s at 8000 g with flow-through being discarded. 
This step was then repeated and centrifuged for 2 min at 8000 g, with flow-through discarded. 
The RNeasy spin column was then moved to a clean 1.5 ml collection tube and 30-50µl RNase-
free water is directly added to the spin column membrane and then centrifuged for 1 min at 8000 
g to elute RNA.  
After quality and quantity analysis by Nano-Drop and Bio-Analyzer (samples given to 
Keck Center for Comparative and Functional Genomics for Bio-Analyzer analysis and all RNA 
Integrity Number  (RIN)  values were above 8.5), RNA samples were given to the Keck Center 
for Comparative and Functional Genomics at the University of Illinois at Urbana-Champaign.  A 
Porcine Agilent Microarray (Santa Clara, CA) was performed using established protocols in the 
Keck Center. Agilent porcine array contains 45,220 probes that are 60 bp in length.  Of these, 
1417 are positive or negative control probes and the other 43,803 were designed to interrogate 
some known pig sequence. The probe content was based on the following databases:  RefSeq 
(Release 38; Nov 2009); Unigene (Release 38; Oct 2009); Ensembl (Release 56; Sep 1, 2009); 
TIGR SSGI (Release 13; Jul 2006); UCSC mrna (Genbank; Nov. 6, 2009); Entrez gene (Dec 
2009); and GO (Dec 2009).   
Bioinformatic analyses were performed by Dr. Jenny Drnevich in the Keck Center for 
Comparative and Functional Genomics.  Briefly, probes that had low CV values across all arrays 
were filtered out.  Of the 45,220 probes, 25,273 probes (58.9%) passed the CV filter. These 
probes’ ANOVA p-values were then corrected using the FDR method. For the “significance” 
threshold, a FDR p-value of 0.2 was selected.  Using a slightly higher cutoff gains more true 
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positives at the expense of a slightly higher false-positive rate. A total of 449 probes had FDR p-
values < 0.2.  The individual sample expression values were corrected for the correlation due to 
being paired on the same array and then clustered using the Weighted Gene Co-expression 
Network Analysis (WGCNA) method (Langfelder and Horvath, 2008). WGCNA uses a very 
sophisticated algorithm to calculate the similarity in expression profiles of probes across all the 
samples, translates these into a dendrogram, and uses a computational method to determine 
which probes belong to the same cluster based on their expression patterns (Langfelder and 
Horvath, 2008). The WGCNA analysis indicated that there are 8 clusters of probes showing 
different expression patterns, indicated by the different color bars in the heatmap (Figure 5.3). 
The Porcine Genebank Accession numbers were submitted to the NCBI HomoloGene database 
to find the human homologs and the Human Ensemble IDs were then entered in Metacore 
software program to generate a list of the most significant canonical pathways (Carlsbad, CA).  
 
Statistical Analysis 
Statistical analysis was first performed using one-way ANOVA according to the General 
Linear Model (GLM) procedure of SAS (SAS Institute, Cary, NC). When significant differences 
were detected within the treatment, least significant difference test was used to identify 
differences between individual means. For all the comparisons, statistical significance was set at 
p ≤ 0.05 and data are expressed as mean ± S.D.  
For body weight gain, the Mixed Procedure of SAS for repeated measures was used. Day 
and diet and day x diet were used in the statistical model. When no significant effects were 
detected for interactions, these were removed from the statistical model. When significant 
differences were detected within the treatment, least significant difference test was used to 
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identify differences between individual means. For all the comparisons, statistical significance 
was set at p ≤ 0.05 and data are expressed as mean ± S.D.  
 
Results  
Piglet weight gain and intestinal length and weight 
There were no differences in weight gain between diet groups over the course of the 
study (Figure 5.4). There were no significant differences in total intestinal length or weight, on 
an absolute basis (g or cm, respectively). However,  normalized by body weight (g/kg or cm/kg, 
respectively) intestinal weight (g/kg BW) was significantly different (p=0.0069) between diet 
groups with FF and FP piglets having the highest intestinal weight, followed by the two 
combined fed groups (CF and CP) and SR had the lowest intestinal weight per kg/BW (Table 
5.1).  
Serum IL-6 and TNF-a Concentrations 
IL-6 and TNF-α were examined in serum samples collected 2h after administration of 
10μg/kg LPS.  Serum IL-6 concentration was highest in FF piglets and significantly different 
from both SR and CF (Table 5.2).  The two prebiotic groups (FP and CP) were intermediate 
between FF, SR and CF. TNF-α was not significantly different among the diet groups (Table 
5.2).  
Immune Cell Phenotype and Percentages 
Immune cell populations were examined in PBMCs, spleen, and MLN.  There were no 
significant differences in DC or Mφ populations among the dietary treatment groups in PBMC, 
MLN or spleen (Table 5.3). However, within the blood (PBMC) there were differences in both 
T-helper (Figure 5.5) and B-cell (Figure 5.6) populations. In regards to T-helper cells 
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(CD3+/CD4+/CD8-), SR had significantly lower populations of these cells in comparison to all 
other diet groups (Figure 5.4). When measuring B-cells, SR had the highest number of cells 
compared to all other diet groups (Figure 5.5).  The MLN also had some diet related differences 
in regards to T-helper (CD3+/CD4+/CD8-) cells (Figure 5.7) and NK cell (Figure 5.8) 
populations.  CP piglets had significantly higher T-helper cell populations in MLN compared to 
FF, FP, CF, but was not different from SR (Figure 5.6). NK cell populations were significantly 
higher (p=0.0214) in CF piglets than FF and FP piglets, with SR and CP being intermediate 
(Figure 5.7).  
Nitric Oxide Production from Isolated Macrophages 
Mφ harvested from both spleen and MLN tissue were tested for nitric oxide synthase 
(NOS) activity, which is a test for classical activation of Mφ.  All diet groups expressed a similar 
level of NOS activity (Table 5.4).  
Arginase Activity in Isolated Macrophages 
Mφ harvested from both SPL and MLN tissue were tested for arginase production 
(Figure 5.9) to measure alternative activation of Mφ. There were no differences in arginase 
activity in the MLN (data not shown).  However, CP piglets had significantly higher arginase 
activity compared to all other diet groups (p<0.0001) (Figure 5.9).  
Transcriptome of the Ascending Colon 
Gene expression was determined in the AC of SR, FF and CF groups by gene microarray. 
Porcine Agilent Microarray and Metacore Software Program (Carlsbad, CA) was used to discern 
gene expression differences.  Human Ensemble IDs were entered into Metacore based on the 
heatmap (Figure 5.3).  Results show 14 main canonical pathways and their associated genes. 
These genes were found within our data and mapped to these established pathways. These 
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pathways included: Regulation of translation initiation, Immune response specifically related to 
MHC-I antigen presentation and another to the Inflammasome, Apoptosis and Survival, Cell 
Migration and Adhesion, Neurophysiological Regulation specifically related to Axon Guidance, 
Nitrogen Metabolism, Biotin Metabolism, Regulation of Lipid Metabolism specifically related to 
Cholesterol and another to PPAR, and Oxidative Phosphorylation. Some of these pathways 
appeared more than once with some genes appearing in more than one pattern on the heatmap.  
The canonical pathways and related genes can be seen in Tables 5.10 and 5.11. 
 
Discussion 
The practice of breastfeeding supplemented with formula, or combined feeding, has become a 
predominant method of early nutrition for the human infant by the 6
th
 month of life (CDC, 2011). 
Thus, it was warranted to investigate the effects of this feeding style on growth, immunity, and 
gene expression.  In order to initiate this line of investigation, it was necessary to develop a new 
experimental model of combined feeding in the piglet.  Our goal was to mimic a feeding pattern 
wherein a mother may initiate exclusive breastfeeding and then move to combined feeding when 
going back to work.  Therefore, piglets were sow-reared for the first 5 d of life, before being 
randomized to combined feeding with our without prebiotic addition. Piglets in all dietary groups 
grew similarly over the duration of the study and had similar intestinal weight and lengths. These 
data suggest that the combined feeding did not induce undue stress in the piglets that could have 
influenced piglet growth.   
The two major outcomes reported herein are immune development and intestinal gene 
expression.  It should be noted that the intestinal microbiota of these piglets has also been 
109 
 
determined in a parallel research project in the laboratory.  Thus, our ultimate goal is to integrate 
the immune and gene expression findings with data on the microbiota.  
A variety of cell populations reflective of both the adaptive and innate arms of the 
immune system were examined. In addition, the response to an immune response elicited by an 
lipopolysaccharide challenge was assessed to enable us to discern differences in their immune 
response to a bacterial challenge.  Two hours post LPS injection, piglets were euthanized and 
blood samples were taken and the pro-inflammatory cytokines IL-6 and TNF-α quantified to 
confirm an acute phase response and to evaluate differences in immune response to the LPS 
challenge.  LPS is recognized by Toll like receptor 4 (TLR4), which is a cell surface receptor and 
found on the surface of Mφ and myeloid DC. TLR 4 requires a small secreted protein, MD-2, as 
part of its cell surface receptor complex, as well as CD14 (Tapping, 2009).  LPS-binding protein 
(LBP) will bind LPS that is released from Gram-negative bacteria and then travel and bind to 
CD14. This binding initiates the signaling pathway that activates the immune system. 
LBP/CD14/MD-2 create a complex with TLR4 on the outer membrane of the macrophage or 
dendritic cell and signal through MyD88 to allow translocation and activation of transcription of 
NF-ĸB.  This transcription will cause secretion of cytokines (IL-6, TNFα) into the infected area 
which will further the immune response (Raetz et al, 2002). Response to TNF-α showed no diet 
related differences. However, there were significant diet related differences with IL6 response to 
LPS. LPS elicited the strongest cytokine response in FF piglets, with the two prebiotic groups 
(FP and CP) responding moderately and SR and CF groups responding with least. Strong 
responses of inflammatory cytokines, including IL-6, in response to pathogens, and in particular 
LPS, have been linked to an increase risk for sepsis (Lakhani and Bogue, 2003). Our results 
show that diet may affect the intensity of an innate immune response to LPS.  Breastfeeding has 
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already been associated with a decreased risk of common childhood ailments (e.g. otitis media, 
acute ear infection) (Ip et al, 2007).  This could possibly be related to the less aggressive IL-6 
response. The prebiotics also helped to lessen the magnitude of IL6 response to LPS compared to 
FF piglets.  
When looking at Mφ activation, it was hypothesized that SR, CF, and CP piglets would 
have more alternatively activated Mφ than FF and FP groups in part due to the exposure of 
immune cells and cytokines that are present in breast milk.  Breast milk contains both TGF-β and 
IL-10, both of which promote tolerance by the immune system and IL-10, in particular, 
encourages alternative activation of Mφ (Brandtzaeg, 2003). Activation of Mφ was measured by 
NO production (classical activation) and urea production (alternative activation; measures 
arginine breakdown by arginase to produce urea).  Our results showed that in the spleen, CP 
piglets had significantly higher expression of alternatively activated Mφ compared to all other 
diet groups. The combination of exposure to sow milk and the prebiotic appeared to encourage 
more alternative activation in this group. The SR and CF groups had relatively low levels of 
alternatively activated Mφ compared to the CP group which was an unexpected result.  Perhaps 
sow milk alone was not sufficient to induce alternative activation, as hypothesized. All diet 
groups had similar expression of classically activated Mφ, which was also unexpected, as it was 
thought that FF piglets would have much higher expression compared to all other diet groups. 
However, it has been shown that an immune response can contain both classical and alternative 
Mφ. As the initial immune response subsides and more IL-10 is present in the environment, it is 
possible for some Mφ to become alternatively activated (Gordon, 1999). As our challenge was 
relatively acute (2h), the entire course of immune reaction was relatively short (data shown in 
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Appendix A). It is entirely possible that we are starting to see early stages of resolution that 
occur after peak reaction to an immune stimulus occurs.  
Immune cell phenotypes were also examined to evaluate possible differences in 
immunity between the combined fed and exclusively-fed groups.  DC, Mφ, NK cells, T-helper, 
and B-cells were measured in spleen, MLN and blood.  DC and Mφ were not significantly 
affected by diet in any tissues.  NK cells showed diet affects in the MLN, but not other tissues. 
NK cells can be activated by NO (Stenger and Rollinghoff, 2001), the same product being used 
in the classical activation pathway for Mφ.  Although our results show there were no statistically 
significant differences between the diet groups and NOS activity in the MLN, there were still 
some variations between diet groups that may be responsible for the differences we see in NK 
cells. As for the T-helper cells, their role in the immune response is to help recruit and direct 
other immune cells including Mφ and B-cells (Murphy et al, 2008).  Our results from the MLN 
showed that CP piglets had the highest percentage of T-helper cells compared to the FF, FP, and 
CF groups, but were not significantly different from SR piglets. In this case, the exposure to sow 
milk as well as prebiotics made the CP piglets express more similarity to SR piglets.  In PBMCs, 
there were significantly lower amounts of T-helper cells in the SR diet group compared to all the 
rest. The SR group also had the highest amount of B-cells compared to all other diet groups. It is 
unknown at this time if these T-helper cells are Th1 or Th2 skewed. Th1 T-helper cells would 
elicit pro-inflammatory cytokines to further an immune reaction and recruit more immune cells 
and could also push Mφ towards the classical activation pathway. Th2 T-cells would instead 
secrete more anti-inflammatory cytokines that would push macrophages to use the alternative 
pathway of activation in addition to activating B-cells and encouraging antibody production. Our 
results show outcomes from both types of T-helper cells. We see an increase in B-cells in the SR 
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group and an increase in arginase activity in the CP group suggesting that these two diets may be 
modulating the immune system to secrete more Th2 type cytokines. However, we also see 
similar levels of NOS between all the diet groups which would suggest that there is Th1 
cytokines being secreted. Further investigation into these immune cells is needed to separate out 
the diet effects on these immune cell phenotypes.  
Finally, microarray analyses were used to investigate the effect of combined feeding on 
gene expression in the colon. Only SR, FF, and CF groups were used. As this is a novel model, 
this analysis was exploratory, but it was hypothesized that genes related to immune function 
would be differentially expressed between FF and CF diet groups and the CF piglets would show 
a pattern more similar to SR. Our results demonstrated that not only genes related to immunity 
were affected, but genes found in that many canonical pathways were also modified by diet, such 
as macronutrient metabolism, apoptosis and survival, as well as oxidative phosphorylation. 
Overall, the CF piglets clustered closer to the FF piglets, but there were certain genes in which 
the CF and SR piglets expressed more similarity, or even times when the CF piglets had their 
own independent pattern of gene expression when compared to the two exclusively fed groups.  
The next step is to verify differential expression of these genes using qPCR and to begin to probe 
potential links between the microbiome and host gene expression as we have previously shown a 
relationship in human infants (Schwart et al, 2012)  
These findings are important because they show that early nutrition impacts the 
development of the immune system, particularly acute immune responses, as well as gene 
expression. We have found that the combined fed piglet does not always ‘choose sides’ and 
mimic one exclusive group, but may be more of a hybrid between the two. There are many 
research studies that consider infants who receive any breastmilk as breastfed.  However, our 
113 
 
data suggest that those infants receiving both breastmilk and infant formula should be considered 
separately from exclusively breastfed or formula-fed infants. In addition, there are many health 
recommendations or expected outcomes based on research done on the two exclusive feeding 
styles that may not necessarily apply to the combined fed group (prevalence of allergic disease, 
future risk of overweight or obesity, etc). Clinical and epidemiological studies in piglet and 
human combined fed neonates should be considered.  
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Table 5.1. Intestinal length and weight of piglets at d21. Intestinal length and weight were measured on d21. There were no 
significant differences intestinal weight or length between diet groups. NS= not significant. Different letter superscripts per row 
indicate statistical significance at p<0.05. 
Mean ± SD. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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  Table 5.2.  Serum IL-6 and TNF-α concentrations of piglets fed formula with or without prebiotic,sow reared, or combined fed 
(formula plus sow milk) with or without prebiotic, 2h Following LPS Injection . There were significant differences related to diet 
within IL-6 expression with FF piglets having a significantly higher response compared to CF and SR piglets, with FP and CP 
piglets having a moderate response.  Different letter superscripts per row indicate statistical significance at p<0.05. 
Mean ± SD. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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  Table 5.3. Macrophage and dendritic cell populations in spleen (SPL), Mesenteric Lymph Node (MLN), and peripheral blood 
mononuclear cells (PBMC).  
Mean ± SD FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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  Table 5.4. Nitric oxide synthase activity (µmol NOS/min/mg prot) in macrophages isolated  from mesenteric lymph node (MLN) 
and spleen.  
Mean ± SD. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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Figure 5.1. Percentage of Infants in the U.S. that are fed exclusively breast milk, exclusively formula, or both in 
hospital (initiation), 6 months and 12 months postpartum.  Combined fed infants are represented in the any BF 
group.  Data from: CDC Breastfeeding Report Card –– United States, 2011.  
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Figure 5.2. Study Design. Newborn piglets (n=44) received colostrum for 3-4 hours and were then randomized to: sow-reared 
(SR: n=24), formula-fed (FF: n=10), and formula-fed + prebiotic (FP: n=10). FP piglets received 2 g/L each of GOS and 
inulin. At day 5, a group (n=16) of the SR piglets were randomized into the “combination feeding” group that were rotated 
between the sow and formula feeding every 12 h.  Combination-fed piglets were further randomized to receive formula with 
(CP: n=8) or without (CF: n=8) prebiotics. On day 21, piglets were administered an intraperitoneal injection of LPS 2h prior 
to euthanasia.  
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Figure 5.3. Heatmap generated by WGCNA analysis from Porcine Agilent Microarray.  This is representative of the differences in 
gene expression between each diet group.  Each diet group clustered together, but separately from each other. The dendogram on the 
right hand side suggests that CF is more similar to FF, but as the patterns are examined, there are areas that both CF and SR share 
more similar gene expression and there are other areas where CF piglets show an independent pattern of gene expression in relation 
to the two exclusive diet groups. Eight distinct patterns of gene expression were observed (see Figures 5.10 and 5.11 for 
representative genes). 
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Figure 5.4. Piglet weight gain over time.  There was no difference in weight gain between the diet groups.  FF= Formula fed, FP= 
Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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Figure 5.5.  PBMC T-helper Cells.  SR had significantly lower populations of circulating T-helper 
(CD3+/CD4+/CD8-) cells compared to all other diet groups. Bars with different letter superscripts indicate 
statistical significance at p<0.05. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= 
Combined+Prebiotic, SR= Sow Reared. 
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Figure 5.6. PBMC  B-cells. SR had significantly higher populations of circulating B-cells (CD3-/MHCII+/CD21+) than all 
other diet groups. Bars with different letter superscripts indicate statistical significance at p<0.05. FF= Formula fed, FP= 
Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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Figure 5.7. MLN T-helper cells. CP piglets had significantly higher populations of T-helper (CD3+/CD4+/CD8-) cells in their 
MLN compared to FF, FP, and CF groups, but was not different from SR. Bars with different letter superscripts indicate 
statistical significance at p<0.05. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, 
SR= Sow Reared. 
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Figure 5.8. MLN natural killer cells. The CF group had significantly higher population of NK cells compared to both FF 
and FP groups with both CP and SR being intermediate. Bars with different letter superscripts indicate statistical 
significance at p<0.05. FF= Formula fed, FP= Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= 
Sow Reared. 
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Figure 5.9. Arginase activity in macrophages isolated from spleen. Macrophages isolated from the spleen of piglets in 
the CP group had significantly higher arginase activity compared to all other groups (p≤0.0001).  FF= Formula fed, FP= 
Formula+Prebiotic, CF= Combined fed, CP= Combined+Prebiotic, SR= Sow Reared. 
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Figure 5.10. Canonical pathways generated from Metacore Software program and the corresponding genes found within AC colon 
samples from FF, CF, and SR piglets. This figure only represents genes found within the corresponding color coded section within 
the heatmap at the left.  FF= Formula fed, CF= Combined fed,  SR= Sow Reared. 
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Figure 5.11. Canonical pathways generated from Metacore Software program and the corresponding genes found within AC 
colon samples from FF, CF, and SR piglets. This figure only represents genes found within the corresponding color coded section 
within the heatmap at the left.  FF= Formula fed, CF= Combined fed, SR= Sow Reared. 
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Chapter 6 
Overall Conclusions and Future Directions 
 
 The overall focus of this dissertation was the effect of early nutrition and/or route of 
delivery on intestinal development and immunity. Three aims were proposed and the conclusions 
from each aim are as follows. 
 The first aim of this study was to examine route of delivery, vaginally derived piglets 
versus cesarean derived piglets, and its effect on microbial colonization and intestine structure 
and function. The overall conclusion from this study was that route did not have the marked 
effect on these parameters as we had thought. We did see some results where route of delivery 
did have an effect. Route effected villus height in the intestine, as well as some parameters of the 
Ussing chamber analysis. VD piglets had higher villi than CD piglets. This was also reflected 
with our weight gain data. There were no overall significant differences in weight gain between 
the two groups, however CD piglets did not gain as much weight as VD piglets after d14 of our 
study. Our Ussing data shows some interesting events happening at d14 that may co-inside with 
the slowing of weight gain as well as decrease in villus height within the CD group. Microbial 
data was also not affected by route. There were differences but it was mostly related to time. 
Weaning had an effect on SCFA acid production with an increase in acetate, propionate, and 
butyrate at d28 in the AC. These also relate to our intestinal permeability data, where we see a 
decrease in colonic permeability at d28 which is possibly related to increased butyrate function. 
These results showed that although, route did not affect our parameters, moving from a milk-
based to a weaning diet definitely modulates intestinal development. We speculated that we did 
not see our anticipated results regarding route of delivery because all of our piglets were sow-
reared and this may have lessened the effect we were trying to see. We proposed a follow up 
study in which route of delivery and diet would be effectors (aim 2). 
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 The second aim of this dissertation focused on the effect of route of delivery and diet on 
intestinal function and immunity. Piglets were born either vaginally or through cesarean section 
and were given one of three diets: formula, formula+prebiotic, or sow milk. The prebiotics 
chosen were polydextrose and scFOS. Once again, there were no effects of route of delivery on 
any of the parameters in this study. However, the addition of prebiotics did show some 
interesting results. Prebiotics seemed to act as a modulator for intestinal enzyme function, 
making FP piglets more similar to SR piglets instead of FF. This effect did not last when we 
looked at ileal CD3+ cell staining. SR had significantly higher populations of cells while FP 
piglets had the lowest. It was concluded that although the addition of prebiotics did create similar 
effects to breast milk , it still is not a complete replacement.  
 The third aim of this dissertation focused a special group of infants that have been under-
studied: the combined fed infant. A third of infants at 6mo of age are being fed breast milk 
supplemented with formula (CDC, 2011), yet there is a large gap in our scientific knowledge as 
to how this different method of feeding is affecting development of the infant compared to those 
that are exclusively fed one diet. We proposed to examine effects of this diet on immunity and 
gene expression. In addition, we decided to carry over one of our prior aims and also examine 
the effect of prebiotics and combined feeding. We had five groups of piglets: FF, FP, CF, CP, 
SR. We injected all piglets with 10μg/kg body weight of LPS to elicit an immune response 2 h 
before euthanasia. There were differences in immune response between groups. FF piglets had a 
significantly higher response in IL-6 compared to the CF and SR groups. There were no diet 
differences with TNF-α. There were significant differences in alternative activation of 
macrophages in the CP group compared to all other diet groups. Immune cell phenotypes showed 
an effect of diet on NK cells, T-helper, and B-cells. Microarray analyses was used to examine 
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gene expression in the AC of FF, CF, and SR piglets. Genes related to immune function, 
macronutrient metabolism, apoptosis and survival, and oxidative phosphorylation were all 
affected. It showed that overall, CF and FF piglets showed more similarity but there are genes in 
which CF shows similar expression to SR and when CF shows its own independent pattern of 
expression. This study showed that nutrition does impact the immune system, particularly 
immune response, as well as gene expression. It showed that the combined fed piglet could be 
considered a hybrid of the two exclusive feeding groups rather than mimicking one group. These 
results led to the conclusion that more clinical and epidemiological studies in piglet and human 
combined fed neonates should be considered.  
 In light of all these results, there are several future studies that can be done utilizing the 
combined feeding model. Our study looked only at acute phase response. It would be interesting 
to see how if these differences in immune response persist if a more serious immune challenge 
were given. It is hypothesized that strong pro-inflammatory reactions to antigen can cause sepsis. 
Our FF piglets had significantly higher IL-6 response to LPS compared to the CF and SR groups.  
Would a larger dose of LPS cause sepsis in all the different diet groups?   
It would also be interesting to see how combined feeding affected response to allergens. 
An allergy model in addition to the combined feeding model could provide interesting insight 
into diet related prevalence of allergy. There are many studies that link breastfeeding with 
prevalence of asthma, and there are also studies that show increased prevalence of allergy in 
formula fed babies. What happens to the child who is fed both? We have already seen that the 
combined fed piglet is somewhat of a hybrid between both exclusive groups. Would this increase 
their prevalence for allergy? 
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The combined feeding piglet model is a very valuable model for investigating real human 
concerns. There are many recommendations and expected outcomes for infants in the two 
exclusive feeding groups that may not apply to the combined fed infant. More research in this 
area should be done to separate out differences between this group and the exclusive feeding 
groups so that the right recommendations and care are being given to these infants.  
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Appendix A 
 
Lipopolysaccharide (LPS) pilot study to determine optimal dosage and timing of peak 
response 
 
Breastfeeding (BF) is the optimal form of nutrition for the infant. However, current data 
suggests that exclusive BF is rare in the U.S.; declining from 77% at birth to 43% at 6 months 
postpartum. At 6 months, only 13% of BF infants are exclusively breastfed, while the other 30% 
are being supplemented with formula (CDC, 2011). Thus, combination feeding, or BF 
supplemented with formula, is a common method of infant feeding, but its effects neonatal 
immune development relative to exclusive breast or formula feeding has not yet been 
determined. To determine whether combined feeding affected the immune response, the immune 
system was challenged prior to sample collection. 
A pilot study was conducted to test the dose response of intraperitoneally (I.P.)-injected 
lipopolysaccharide (LPS; Escherichia coli serotype K-235). Twenty-one do piglets (n=9) were 
randomized into 3 dosage groups: 2.5, 5 or 10µg/kg body weight. Blood was collected from the 
jugular at baseline and every 2h post injection for 8h (Figure A.1). Rectal temperature (Figure 
A.2) was taken before every bleeding and all piglets were kept under constant observation. 
Piglets had constant access to the sow for food throughout the entire study. Piglets were 
euthanized 8h post-injection.  IL-6 and TNF-α cytokines were measured using Enzyme Linked 
Immunosorbent Assay (ELISA). IL-6 concentrations were affected by dose (p=0.0075) and time 
(p=0.0004), with 10μg/ kg and 2h generating the most robust response (Figure A.3). TNF-α 
concentration in the blood peaked at 2h post injection (p<0.0001) (Figure A.4). Based on these 
results, the LPS dose of 10µg/kg was selected to be administered 2h prior to euthanasia. 
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Figure A. 1: Pilot Study Design.  
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Figure A. 2: Rectal temperature taken from piglets over 8 hours.  
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Figure A. 3: IL-6 ELISA. Piglet serum was tested for IL-6 response over time. IL-6 was  
significant between doses (p=0.0075) and between time (p=0.0004) with 10μg/ kg and 2 
hours being the most significant compared to all other time points and doses 
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Figure A. 4: TNF-α ELISA. Piglet serum was tested for TNF-α response over time. 
The 2 hour post injection time point was significantly different from all others 
(p<0.0001).  
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Appendix B 
Porcine Agilent Gene Microarray: Probe sets that were differentially expressed within 
ascending colon samples of sow reared, formula fed, and combined fed piglets. 
 
Ascending colon samples were collected from 21 do piglets from three different diet 
treatment groups: sow reared, formula fed, and combine fed (sow milk supplemented with 
formula). Details of the study design are described  in Chapter 5.  
A porcine specific Agilent microarray was performed using RNA extracted from 
ascending colon of piglets in each diet treatment group. The microarray contained 45,220 probe 
sets. From this only 25, 273 probe sets were expressed within the samples and from this only 449 
probe sets were significantly differentially expressed at a false discovery rate (FDR) of 0.2. The 
probe sets that were significant are found in Table B.1. This table includes the gene symbol, the 
mean expression values of each gene within each diet treatment group, the associated heatmap 
cluster color (see Figure 5.3), porcine Gene bank Accession number, and the corresponding 
Human Ensemble ID.  
The genes are also shown as fold change amongst diet groups in Table B.2. Only genes 
that had a fold change of ±1.5 or higher were included in the table along with their gene symbol 
and heatmap (Figure 5.3) cluster color. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
TSPAN6 11.83 11.66 12.14 blue AK232321 ENSG00000000003 
FH 8.94 9.34 9.72 red NM_214281 ENSG00000000971 
CYP51 11.34 11.90 11.86 yellow NM_214432 ENSG00000001630 
CYP51 9.49 10.21 9.76 yellow NM_214432 ENSG00000001630 
CASP10 15.82 15.67 15.44 turquoise NM_001161640 ENSG00000003400 
PDK4 9.37 7.55 8.57 turquoise NM_001159306 ENSG00000004799 
PDK4 10.33 8.66 9.85 turquoise NM_001159306 ENSG00000004799 
PDK4 11.56 9.66 10.90 turquoise NM_001159306 ENSG00000004799 
PDK4 9.32 7.59 8.74 turquoise NM_001159306 ENSG00000004799 
PDK4 7.80 6.62 7.53 green NM_001159306 ENSG00000004799 
PDK4 11.15 9.30 10.56 blue NM_001159306 ENSG00000004799 
PDK4 8.53 7.15 8.13 blue NM_001159306 ENSG00000004799 
PDK4 8.90 7.14 8.20 blue NM_001159306 ENSG00000004799 
PDK4 5.86 5.60 5.81 blue NM_001159306 ENSG00000004799 
MGST1 10.68 11.01 11.18 turquoise NM_214300 ENSG00000008394 
SLC11A1 6.36 7.02 6.35 turquoise NM_213821 ENSG00000018280 
Table B.1: Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, associated 
heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= Formula Fed, 
SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
KCNG1 7.83 7.91 7.26 turquoise NM_001113450 ENSG00000026559 
SARS 12.31 12.79 12.34 brown AK233655 ENSG00000031698 
RAD51 7.27 7.54 7.67 turquoise NM_001123181 ENSG00000051180 
DGAT2 6.45 5.84 6.14 turquoise NM_001160080 ENSG00000062282 
SUSERK3 8.28 8.57 8.85 yellow XM_001925291 ENSG00000069956 
SUSERK3 10.57 10.91 11.15 turquoise XM_001925291 ENSG00000069956 
ITM2A 8.86 8.25 8.65 turquoise NM_001031798 ENSG00000078596 
RAB10 9.40 9.80 9.89 turquoise AK350491 ENSG00000084733 
NOP14 11.30 11.73 11.10 red AK350879 ENSG00000087269 
RPL6 14.29 14.05 14.72 red NM_001044542 ENSG00000089009 
RPL6 14.03 13.85 14.48 black NM_001044542 ENSG00000089009 
RPL6 14.29 14.03 14.71 brown NM_001044542 ENSG00000089009 
LOC100156323 5.90 5.93 6.11 green XM_001929075 ENSG00000090060 
ZNF268 7.42 7.40 6.93 turquoise XM_001927940 ENSG00000090612 
PCPA1 6.47 5.76 6.67 blue NM_214244 ENSG00000091704 
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
153 
 
       
       
       
 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
SCD 8.40 9.86 8.40 turquoise NM_213781 ENSG00000099194 
SCD 10.19 11.79 10.35 turquoise NM_213781 ENSG00000099194 
SCD 10.81 12.27 10.80 turquoise NM_213781 ENSG00000099194 
SCD 10.67 12.25 10.73 turquoise NM_213781 ENSG00000099194 
SCD 9.40 10.96 9.45 turquoise NM_213781 ENSG00000099194 
SCD 9.29 10.80 9.35 brown NM_213781 ENSG00000099194 
SCD 7.48 8.65 7.57 blue NM_213781 ENSG00000099194 
LOC100516774 6.63 6.75 7.02 brown XM_003121879 ENSG00000099810 
LOC100521622 11.70 11.45 11.24 yellow XM_003126021 ENSG00000100242 
LOC100154408 9.87 10.00 10.26 green AY610111 ENSG00000100567 
SRSF5 9.18 9.27 8.82 black XM_001927419 ENSG00000100650 
PSMA6 11.75 11.87 12.23 yellow NM_001139472 ENSG00000100902 
LOC100515986 8.95 9.53 9.33 turquoise XM_003135231 ENSG00000101811 
STS 14.43 14.45 13.80 yellow XM_003360223 ENSG00000101846 
UF 11.74 12.83 11.78 red NM_214209 ENSG00000102575 
UF 6.75 7.66 6.81 brown NM_214209 ENSG00000102575 
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession number Human Ensemble ID 
CPE 8.04 7.65 7.81 turquoise NM_001097439 ENSG00000109472 
C1H9orf46 10.58 10.37 11.20 turquoise NM_001190217 ENSG00000107020 
SQLE 10.13 10.91 10.30 turquoise NM_001101026 ENSG00000104549 
SQLE 9.96 10.75 10.16 brown NM_001101026 ENSG00000104549 
SLC1A5 11.11 11.58 11.01 black AK349144 ENSG00000105281 
SLC1A5 10.60 11.12 10.62 green AK349144 ENSG00000105281 
CCL8 6.59 7.19 6.46 turquoise NM_001164515 ENSG00000108700 
NDUFC1 10.58 10.79 11.18 brown NM_001097470 ENSG00000109390 
LOC100157055 9.21 9.36 9.72 brown AK233242 ENSG00000110871 
LOC100155956 10.04 10.28 10.59 brown AK232287 ENSG00000110958 
NOP2 9.53 10.02 9.61 brown AK345763 ENSG00000111641 
COX6A1 14.58 14.85 14.95 turquoise NM_001190221 ENSG00000111775 
COX6A1 14.48 14.62 14.88 blue NM_001190221 ENSG00000111775 
LOC100157860 8.39 8.45 8.86 brown XM_001928398 ENSG00000111802 
RPS12 15.11 15.18 15.50 yellow NM_214363 ENSG00000112306 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment 
group, associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined 
Fed, FF= Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
TMEM59 10.06 9.69 10.17 turquoise NM_001044558 ENSG00000116209 
ACTR3 6.42 6.58 6.81 brown NM_001134343 ENSG00000115091 
CCNG1 7.23 6.87 7.49 turquoise NM_001031781 ENSG00000113328 
SELK 9.62 9.37 9.93 green NM_001044553 ENSG00000113811 
SPCS1 10.83 10.90 11.44 black NM_001114288 ENSG00000114902 
SPCS1 10.36 10.44 10.86 brown NM_001114288 ENSG00000114902 
ACTR3 10.03 10.18 10.41 yellow NM_001134343 ENSG00000115091 
ITGA4 6.32 6.24 6.76 turquoise XM_003133517 ENSG00000115232 
MOBKL3 8.59 8.33 8.93 red NM_001032379 ENSG00000115540 
SUMO1 12.32 12.15 12.60 turquoise AY609886 ENSG00000116030 
TMEM59 11.15 10.74 11.32 turquoise NM_001044558 ENSG00000116209 
LOC100156038 10.19 10.72 10.33 turquoise AK239721 ENSG00000116455 
LOC100156749 10.94 10.89 11.33 turquoise AY609785 ENSG00000116586 
GBP1 10.56 11.62 11.60 brown NM_001128473 ENSG00000117228 
TXNIP 13.73 13.11 13.46 red AK349227 ENSG00000117289 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment 
group, associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= 
Combined Fed, FF= Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
PCK1 7.75 7.10 7.30 turquoise NM_001123158 ENSG00000124253 
P4HA1 6.40 6.11 6.44 yellow NM_001097435 ENSG00000122884 
BLZF1 9.00 9.29 9.50 turquoise AK230832 ENSG00000117475 
LOC100151927 11.86 11.69 12.37 turquoise EV982725 ENSG00000123349 
LOC100151927 7.98 7.71 8.41 blue EV982725 ENSG00000123349 
MXI1 6.79 6.52 6.87 blue XM_001925277 ENSG00000119950 
LOC100520896 10.22 10.52 10.60 pink XM_003123975 ENSG00000120705 
CCR2 6.06 6.12 6.57 green NM_001001619 ENSG00000121807 
MYOG 8.44 8.35 7.84 turquoise NM_001012406 ENSG00000122180 
RPL5 15.01 14.72 15.20 yellow NM_001114284 ENSG00000122406 
RPL5 15.57 15.38 15.80 turquoise NM_001114284 ENSG00000122406 
PCK1 10.42 9.16 9.63 turquoise NM_001123158 ENSG00000124253 
PCK1 10.81 9.59 9.97 turquoise NM_001123158 ENSG00000124253 
RAB14 6.64 6.92 7.05 brown AK236065 ENSG00000119396 
MXI1 9.09 8.49 9.03 green XM_001925277 ENSG00000119950 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
CD36 8.66 7.79 8.40 yellow NM_001044622 ENSG00000135218 
PCK1 10.09 9.04 9.47 brown NM_001123158 ENSG00000124253 
MCEE 8.48 8.48 9.00 yellow NM_001097471 ENSG00000124370 
GLO1 6.92 6.98 7.34 brown AK237209 ENSG00000124767 
HCST 7.74 7.73 8.25 brown NM_214142 ENSG00000126264 
COX7C 13.56 13.68 14.09 turquoise NM_001097474 ENSG00000127184 
DGCR8 10.02 10.07 9.80 turquoise NM_001206919 ENSG00000128191 
ATF4 12.13 12.70 11.98 yellow NM_001123078 ENSG00000128272 
LDLR 10.99 11.82 11.13 turquoise AK236400 ENSG00000130164 
LDLR 10.03 10.76 9.96 brown AK236400 ENSG00000130164 
ATPIF1 13.42 13.37 13.83 yellow NM_001097486 ENSG00000130770 
UBE2D2 9.82 9.96 10.23 yellow NM_001078673 ENSG00000131508 
LOC100158002 10.33 10.17 10.65 brown XM_001928953 ENSG00000132541 
SLC2A11 12.90 12.96 12.37 turquoise XM_003132985 ENSG00000133460 
BTG1 7.51 7.33 7.94 red NM_001099936 ENSG00000133639 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
CNPY3 15.30 15.42 14.75 turquoise NM_001110428 ENSG00000137161 
SLC37A4 14.94 14.99 14.45 green AK232354 ENSG00000137700 
OSTF1 9.61 9.79 10.15 red NM_214005 ENSG00000134996 
GPNMB 8.56 10.60 8.58 blue AK230588 ENSG00000136235 
TXN 12.37 12.55 13.05 turquoise NM_214313 ENSG00000136810 
MCL1 9.10 9.60 9.70 brown NM_214361 ENSG00000143384 
S100A8 6.69 6.27 7.39 green NM_001160271 ENSG00000143546 
PNAS-5 9.18 9.75 9.68 turquoise AY550061 ENSG00000145220 
RPL7L1 11.78 12.11 12.19 red NM_001123192 ENSG00000146223 
HMBOX1 9.59 9.69 9.24 turquoise AK232025 ENSG00000147421 
LOC100153622 14.82 14.88 14.28 blue AK347227 ENSG00000147454 
RPL7 14.03 13.89 14.39 black NM_001113217 ENSG00000147604 
EIF4E 7.83 8.02 8.38 turquoise AK343970 ENSG00000151247 
FAM177A1 8.81 9.09 9.24 turquoise NM_001190218 ENSG00000151327 
       
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment 
group, associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= 
Combined Fed, FF= Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
IFNAR2 15.51 15.66 15.11 pink NM_001204775 ENSG00000159110 
LOC100521561 
9.97 9.88 10.41 turquoise AK346127 ENSG00000162368 
AZIN1 
7.52 7.67 7.85 green AK230591 ENSG00000155096 
RBM45 
6.85 7.18 7.29 turquoise XM_003133507 ENSG00000155636 
LOC100158051 
7.84 7.83 8.32 turquoise AK344688 ENSG00000156171 
FBXO32 
12.27 11.68 11.35 green AK231687 ENSG00000156804 
NCK1 
10.22 10.16 10.67 turquoise AK233065 ENSG00000158092 
S100A12 6.06 5.80 7.00 green NM_001160272 ENSG00000163221 
KLF15 7.76 7.18 7.23 turquoise NM_001134349 ENSG00000163884 
CASP3 10.15 10.50 10.49 turquoise AK230496 ENSG00000164305 
CMYA5 6.16 6.04 5.80 turquoise NM_001197307 ENSG00000164309 
CA3 6.94 5.83 6.29 yellow DQ157049 ENSG00000164879 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
B2M 12.76 12.85 13.50 blue DQ845172 ENSG00000166710 
B2M 10.76 10.91 11.59 blue DQ845172 ENSG00000166710 
CA3 8.63 6.83 7.62 turquoise NM_001008688 ENSG00000164879 
CA3 9.39 7.34 8.21 red NM_001008688 ENSG00000164879 
CA3 
8.48 6.72 7.44 black NM_001008688 ENSG00000164879 
CA3 8.18 6.66 7.34 brown NM_001008688 ENSG00000164879 
CA3 8.46 6.83 7.51 green NM_001008688 ENSG00000164879 
TRPV6 10.60 10.80 9.52 blue FJ268731 ENSG00000165125 
HPRT1 9.57 9.74 10.00 turquoise NM_001032376 ENSG00000165704 
LOC100523311 6.48 6.29 6.75 black XM_003126092 ENSG00000166046 
B2M 13.58 13.85 14.50 red AK239552 ENSG00000166710 
B2M 12.63 12.75 13.39 black DQ845172 ENSG00000166710 
C7H14orf142 10.79 10.91 11.38 turquoise NM_001167590 ENSG00000170270 
FABP4 7.85 6.29 6.93 turquoise NM_001002817 ENSG00000170323 
       
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
LOC100158015 10.33 10.75 10.96 turquoise AK235607 ENSG00000170348 
SLC30A1 6.54 6.98 6.73 turquoise NM_001139470 ENSG00000170385 
FABP4 10.84 8.85 9.73 turquoise NM_001002817 ENSG00000170323 
FABP4 11.57 9.56 10.60 red NM_001002817 ENSG00000170323 
FABP4 8.78 6.80 7.74 brown NM_001002817 ENSG00000170323 
FABP4 9.39 7.43 8.35 brown NM_001002817 ENSG00000170323 
FABP4 10.33 8.11 9.34 blue NM_001002817 ENSG00000170323 
NT5DC1 
9.72 10.18 10.39 yellow XM_001928200 ENSG00000178425 
NT5DC1 9.64 10.12 10.19 red XM_001928200 ENSG00000178425 
AMBN 6.56 6.84 7.03 turquoise NM_214037 ENSG00000178522 
ADIPOQ 10.49 7.93 8.47 yellow EF601160 ENSG00000181092 
RNASE4 7.98 7.37 7.97 turquoise NM_213936 ENSG00000181784 
SLC2A4 8.90 8.62 8.05 turquoise NM_001128433 ENSG00000181856 
LOC100153245 15.04 15.12 14.40 blue XM_001925439 ENSG00000182325 
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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 Mean Expression Value    
Gene Symbol CF FF SR 
Heatmap 
Cluster 
Gene bank Accession 
number 
Human Ensemble ID 
RYR2 6.39 6.28 6.13 turquoise XM_001924768 ENSG00000198626 
RPL10A 15.13 14.87 15.36 turquoise NM_001097477 ENSG00000198755 
C15H4orf47 6.18 6.12 6.50 turquoise NM_001190210 ENSG00000205129 
PSMB9 10.75 11.25 11.53 yellow NM_001037961 ENSG00000240065 
PSMB9 10.51 11.28 11.65 black NM_001037961 ENSG00000240065 
ATP5J2 13.95 14.03 14.29 blue NM_001097464 ENSG00000241468 
LOC100154344 6.31 6.28 6.67 turquoise XM_001929616 ENSG00000242259 
ATP5L 13.25 13.39 13.86 blue AK238581 ENSG00000249222 
SEPP1 9.60 8.92 9.57 green NM_001134823 ENSG00000250722 
LOC100524500 14.63 14.71 15.12 blue AK349259 ENSG00000182952 
LOC100153642 
6.76 6.51 7.22 turquoise XM_001927723 ENSG00000186352 
TECPR2 14.73 14.73 14.02 turquoise AK238577 ENSG00000196663 
HDH 7.86 7.92 7.43 brown NM_213964 ENSG00000197386 
TPM2 13.14 12.67 12.25 turquoise NM_001129947 ENSG00000198467 
 
Table B.1(Cont’d): Probe sets with FDR of 0.2. Gene symbol, mean expression value or each gene within diet treatment group, 
associated heatmap cluster color, Gene bank Accession number, and Human Ensemble ID are listed. CF= Combined Fed, FF= 
Formula Fed, SR= Sow Reared. 
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Gene Symbol CF vs SR CF vs FF FF vs SR Heatmap cluster color 
PSMB9 -2.2046 -1.7038 -1.29393 black 
GBP1 -2.05697 -2.08684 1.01452 brown 
S100A12 -1.91074 1.202428 -2.29752 green 
B2M -1.88503 -1.20102 -1.56953 red 
B2M -1.78587 -1.1136 -1.6037 blue 
LOC100152534 -1.73542 -1.16894 -1.48462 blue 
FH -1.71462 -1.31789 -1.30103 red 
PSMB9 -1.71345 -1.41809 -1.20828 yellow 
LOC100152534 -1.70718 -1.18748 -1.43765 turquoise 
B2M -1.69593 -1.08518 -1.56281 black 
LOC100152534 -1.68848 -1.16553 -1.44868 turquoise 
CYCS -1.62478 -1.36435 -1.19088 blue 
S100A8 -1.62314 1.335738 -2.16809 green 
EMP1 -1.61211 -1.32875 -1.21325 brown 
TXN -1.60389 -1.13335 -1.41517 turquoise 
NT5DC1 -1.59126 -1.37404 -1.15808 yellow 
LOC100158015 -1.5449 -1.33246 -1.15943 turquoise 
Table B.2: Fold Change between diet treatment groups. This table represents the genes found within the significant probe sets that 
have a fold change of ±1.5 fold change or higher.  CF= Combined Fed, FF= Formula Fed, SR= Sow Reared. 
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Gene Symbol CF vs SR CF vs FF FF vs SR Heatmap cluster color 
C1H9orf46 -1.53909 1.154578 -1.777 turquoise 
SPCS1 -1.52226 -1.05251 -1.44632 black 
ATP5L -1.51839 -1.10068 -1.3795 blue 
MCL1 -1.51816 -1.41635 -1.07188 brown 
NDUFC1 -1.516 -1.15738 -1.30985 brown 
MCL1 -1.51816 -1.41635 -1.07188 brown 
NDUFC1 -1.516 -1.15738 -1.30985 brown 
PDK4 1.506376 3.602898 -2.39176 blue 
MYOG 1.507654 1.062073 1.419538 turquoise 
STS 1.541369 -1.01299 1.561396 yellow 
PCK1 1.546146 2.076011 -1.3427 brown 
LOC100153245 1.562933 -1.0596 1.65609 blue 
CA3 1.573837 2.164619 -1.37538 yellow 
LOC100510968 1.577733 1.080957 1.459571 yellow 
PDK4 1.581358 3.731024 -2.35938 turquoise 
GPD1 1.628809 1.749222 -1.07393 turquoise 
TECPR2 1.63681 1.001225 1.634807 turquoise 
Table B.2 (Cont’d): Fold Change between diet treatment groups. This table represents the genes found within the significant 
probe sets that have a fold change of ±1.5 fold change or higher.  CF= Combined Fed, FF= Formula Fed, SR= Sow Reared. 
165 
 
 
 
     
     
     
Gene Symbol CF vs SR CF vs FF FF vs SR Heatmap cluster color 
CA3 1.787247 2.856541 -1.59829 brown 
S100G 1.804458 -1.73014 3.121962 yellow 
SLC2A4 1.806737 1.211577 1.491227 turquoise 
THBS3 1.842508 1.116837 1.649756 blue 
TPM2 1.854484 1.388285 1.335809 turquoise 
FABP4 1.883316 2.934968 -1.5584 turquoise 
FBXO32 1.892137 1.508948 1.253944 green 
CA3 1.927351 3.098842 -1.60782 green 
FABP4 1.961503 4.031327 -2.05522 red 
FABP4 1.981292 4.657172 -2.35057 blue 
CA3 2.014327 3.469671 -1.7225 turquoise 
CA3 2.024037 3.154971 -1.55875 turquoise 
CA3 2.051757 3.386889 -1.65073 black 
FABP4 2.054898 3.932093 -1.91352 brown 
TRPV6 2.117193 -1.14854 2.431676 blue 
FABP4 2.158624 3.972068 -1.84009 turquoise 
CA3 2.267526 4.133853 -1.82307 red 
ADIPOQ 4.060258 5.917838 -1.4575 yellow 
Table B.2 (Cont’d): Fold Change between diet treatment groups. This table represents the genes found within the significant 
probe sets that have a fold change of ±1.5 fold change or higher.  CF= Combined Fed, FF= Formula Fed, SR= Sow Reared. 
